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Summary 
 
All animals, from simple flies to humans, rely on a functional muscle system to produce 
and coordinate their sophisticated movements. Our muscle system has evolved to 
perform specific behaviors such as feeding, mating, and laughing among many others. 
Interestingly, apart from the general myogenic regulatory factors, many specialized 
transcription factors are recruited to cooperate with the core transcription factors to 
instruct the different developmental processes building different muscle types. 
However, how such a cooperation works, in particular how it can instruct 
myofibrillogenesis and sarcomerogenesis in a muscle specific way is largely unknown. 
To tackle this problem, I used a well-established model, the Drosophila melanogaster 
indirect flight muscles (IFMs), to explore the function of new players that instruct 
muscle development, which may discover novel principles potentially conserved to 
human muscle biology. 
In the first part of the thesis, I have successfully established TALEN induced 
mutagenesis in Drosophila. With TALEN, I generated mutants for several candidate 
genes, including CG11617, salr, and CG32121 (fallen angel, fall). We found that a loss 
of function allele of fall causes a flightless phenotype, while the flies are viable. 
Surprisingly, mutations in CG11617, a previously uncharacterized putative transcription 
factor, did not result in any obvious muscle phenotype in Drosophila.  
In the second part I took genome editing a step further and developed an efficient two-
step genome engineering strategy by combining CRISPR with recombinase-mediated 
cassette exchange (RMCE) and successfully adapted it to mutate and tag salm as well as 
fall. We standardized this protocol and applied it to manipulate many other favorite 
candidates genes in our lab at high efficiencies.  
In the third part of my thesis, I could show that Fall, a novel BTB-zinc finger protein, is 
essential for correct IFM development. Null alleles of fall lead to hypercontracted 
muscle fibers resulting in rupturing of the muscle-tendon system and muscle atrophy. 
We found that Fall protein is capable to form nuclear bodies, which are distinct from 
insulator bodies. Structure-function analysis of Fall showed that both BTB domain and 
zinc finger domains are essential for Fall to regulate downstream targets, while only the 
 x 
BTB domain is important for Fall to enter nucleus and form nuclear bodies. Most 
importantly, we found that Fall regulates the expression of many sarcomeric 
components specifically required for sarcomere maturation in order to enable normal 
sarcomere growth during flight muscle development. Our results suggest that 
myofibrillogenesis initiation and sarcomere maturation are regulated by a distinct set of 
transcriptional regulators ensuring proper formation of the final pseudo-crystalline 
sarcomeric organization of the flight muscles.  
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Zusammenfassung 
 
Alle Tiere, ob kleine Fliegen oder komplexe Menschen, benötigen ein funktionelles 
Muskelsystem für ihre ausgeklügelten Bewegungen. Unser Muskelapparat hat sich 
entwickelt, um ein Vielzahl von Verhaltensweisen, wie Fressen,  Lachen oder Sex 
unterstützen zu können. Für die korrekte Entwicklung werden interessanterweise neben 
den generellen Muskelschaltergenen eine Reihe von spezialisierten 
Transkriptionsfaktoren rekrutiert, um mit den Kern Transkriptionsfaktoren zu 
kooperieren. Auf diese Weise werden die verschiedenen Entwicklungsschritte, die zur 
Entwicklung der unterschiedlichen  Muskelarten führen, gesteuert. Wie genau die 
Kooperation der verschiedenen Faktoren funktioniert, um die Myofibrillen und 
Sarkomerbildung zu steuern, ist unbekannt. Ich habe das etablierte Model der indirekten 
Flugmuskulatur von Drosophila melanogaster ausgewählt, um dieses Problem zu 
anzugehen und die Funktion von neuen Regulatoren der Muskelentwicklung zu 
studieren. Dies könnte zur Entdeckung neuer Mechanismen führen, die auch für die 
Muskelbiologie des Menschen wichtig sein könnten. 
Im ersten Teil meiner Arbeit habe ich die TALEN induzierte Mutagenese in Drosophila 
etabliert. Mittels TALENs habe ich Mutanten in mehreren Kandidatengenen, inklusive 
CG11617, salr und CG32121 (fallen angel, fall) hergestellt. Wir haben herausgefunden, 
dass ein Fuktionsverlust von fall zu lebenden Fliegen führt, die allerdings völlig fluglos 
sind. Erstaunlicherweise führen Mutationen in CG11617, einem vorher nicht studierten 
wahrscheinlichen Transkriptionsfaktor, zu keinem offensichtlichen Phänotyp. 
Im zweiten Teil meiner Arbeit habe ich das Genome Editing einen Schritt weiter 
gebracht und habe eine effiziente Zweischritt-Strategie für die gezielte Genveränderung 
entwickelt. Für diese Strategie habe ich CRISPR mit recombinase mediated cassette 
exchange (RMCE) kombiniert und erfolgreich angewandt, um damit Mutationen in 
salm und fall herzustellen und einen "Tag" in diese Gene einzubauen. Wir haben diese 
Protokoll weiter standardisiert und für die gezielte Veränderung einer ganzen Reihe von 
anderen Genen im Labor mit hoher Ausbeute angewandt. 
Im dritten Teil meiner Arbeit konnte ich zeigen, dass Fall, ein neuer BTB-Zinkfinger 
Transkriptionsfaktor essentiell für die normale Flugmuskel Entwicklung ist. Genetische 
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Nullallele in fall führen zu Muskel Hyperkontraktionen und einem Zerreißen des 
Muskel-Sehen Systems, mit Muskelatrophy als Folge. Wir haben entdeckt, dass das Fall 
Protein im Zellkern zu Strukturen lokalisiert, die verschieden von den 
"Insulatorkörpern" sind. Mittels Struktur-Funktionsanalyse von Fall konnten wir zeigen, 
dass sowohl die BTB, als auch die Zinkfinger Domäne von Fall benötigt werden, um 
nachgeschaltete Zielgene zu regulieren. Dabei ist nur die BTB Domäne für den 
Kernimport und die Lokalisierung  zu den Kernstrukturen notwendig. Die wichtigste 
Erkenntnis ist, dass Fall die Expression von vielen Sarkomer Bausteinen reguliert, die 
spezifisch für die Reifung der Sarkomere benötig werden. Zusammen erlaubt dies ein 
normales Sarkomerwachstum während der Flugmuskelentwicklung. Unsere Ergebnisse 
legen nahe, dass der Beginn der Myofibrillen Bildung und das Reifen der Sarkomere 
von unterschiedlichen Sätzen an transkriptionellen Regulatoren gesteuert wird. So wird 
sicher gestellt, dass die pseudo-kristalline Organisation der Sarkomere in den 
Flugmuskeln richtig ausgebildet wird. 
 
 
 
Introduction 
 1 
1 Introduction 
A highly coordinated muscle system is indispensible for the daily life of animals, 
including simple insects and complex humans. During development, various muscles 
with different properties, shapes, and functions are built for their special needs at defined 
positions of our body. Muscle specialization is exemplified by comparing the muscles 
from a 100 meter runner to a marathon runner. The former ones are specialized to 
perform high mechanical work at the expense of endurance, while the latter are 
designated for long endurance workload. Imaging that the eyelid blinks once every 
minute, while the heart beats every second, one can easily appreciate the finely designed 
and coordinated muscle systems in the human body. Interestingly, the basic code, namely 
myogenic regulatory factors such as MyoD, Myf5, myogenin and MRF4 are shared by 
many different muscle types in different organs (Buckingham, 2001; 2006). How these 
core transcription factors are combined with muscle-type specific regulators to instruct 
functional muscle specialization is less clear. 
The fruit fly, Drosophila melanogaster, has been used as a model for developmental 
biology and genetics over a century. Tremendous discoveries made in flies established 
the biological similarity between Drosophila melanogaster and mammals (Wangler et 
al., 2015). And not surprisingly, flies and mammals share many features in muscle 
development (Taylor, 2006). First, more than 60% of the 13,000 proteins that are 
encoded by the fly genome showed sequence similarity with human proteins, which 
indicates the fundamental similarity between Drosophila and vertebrate in general 
(Rubin, 2001). Second, in vertebrates, three categories of muscles, including skeletal, 
heart, and smooth muscles have been classified according to their structural and 
functional properties. Although the physiological characters differ, the somatic, the heart, 
and the visceral musculature of Drosophila are the anatomical and functional 
counterparts of these three classes. Finally, the mechanisms underlying muscle 
development show that the main processes of muscle formation including determination 
of myogenic identity, specification of muscle precursors, myoblast fusion, 
myofibrillogenesis, and sarcomerogenesis require the coordinated actions of 
evolutionarily conserved genes in both Drosophila and humans. The large variety of 
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genetic tools and its manipulation make the Drosophila muscular system, especially the 
adult muscles, an excellent model to dissect mechanisms of muscle morphogenesis. 
1.1 Skeletal muscles 
1.1.1 Overview of muscle structure 
 
 
Figure 1: Scheme of skeletal muscle morphology (modified from Anatomy and Physiology, an OpenStax 
resource: http://philschatz.com/anatomy-book/contents/m46476.html) 
In vertebrates, muscles are categorized into three types: skeletal, heart and smooth 
muscles. They share prominent common properties such as tissue contraction apart from 
diverse physiological functions. Here I take skeletal muscles as an example to illustrate 
the basic morphology of muscle tissues (Figure 1). Skeletal muscles generally form a 
cylindrical, spindle-like tissue, which is linked to the skeleton by connective tissue. 
Muscles are excitable and can contract upon neuronal stimulation. Each muscle is 
encapsulated in a sheath of connective tissue called epimysium that maintains muscle 
integrity during contraction by separating it from surrounding tissues. The inside space of 
the epimysium is filled with dozens of muscle fascicles, which are composed of 
organized muscle fiber bundles and are incased by a perimysium. Each muscle fiber is a 
Introduction 
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muscle cell, which is a multinucleated syncytial cell. Inside of the muscle fibers are well-
aligned hundreds to thousands myofibrils. 
 
Figure 2: Sarcomere structure (modified from (Lemke and Schnorrer, 2016)). 
M-line lies in the middle of a sarcomere. α-actinin localizes to Z disc and anchors actin filaments. The 
main components of sarcomere, actin based thin filaments and myosin based thick filaments, are 
interdigitated. The I-band spans the region that without thick filaments, while the A-band spans the region 
occupied by thick filaments. The H-zone is the thin filaments free region. Titin connects thin and think 
filaments. 
The most striking appearance of myofibrils is cross-striation, a pattern characterized by 
the alternating light (I-band, isotropic in polarized light) and dark bands (A-band, 
anisotropic in polarized light) observed under light microscope. This feature is directly 
caused by the highly ordered organization of the myofibrils, the mini-machines called 
sarcomeres, and their repetitive alignment along the myofibrils in a longitudinal manner 
(Clark et al., 2002). The fundamental contractile unit of each muscle fiber is the 
sarcomere. It is made of numerous sophisticated macromolecular protein complexes. 
Among them are the actin based thin filaments and myosin based thick filaments, as well 
as titin based elastic filaments (Figure 2). Each sarcomere is centered around the M-line 
and bordered by two Z discs, to which the thin filaments are cross-linked. The thin 
filaments originate from both Z discs, span the I-band, and point towards the M-line. 
They overlap with thick filament in the A-band but do not reach the M-line. The thin 
filaments free space is defined as H zone. The bipolar thick filaments are centered at the 
M-line and define the A band. They point towards the actin filaments, with which they 
overlap (Ehler and Gautel, 2008).  
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These actin and myosin based complexes form an almost crystalline order. The relative 
position and arrangement between the two kinds of filaments were resolved by electron 
microscopic studies. In longitudinal sections of muscle fibers, the thin and thick 
filaments align in parallel. Interestingly, in cross sections, a hexagonal array of thin 
filaments surrounding each thick filament was observed. These structural arrangements 
resulted in the proposition of the sliding filament theory of muscle contraction (Huxley, 
2004). 
1.1.2 Sliding-filament theory and cross-bridge model of 
muscle contraction 
Skeletal muscles function mostly by producing mechanical force resulting in muscle 
contraction. A substantial body of studies has been performed to dissect the sarcomeric 
architecture and the mechanisms underlying muscle contraction. Decades ago, the sliding 
filament theory has been proposed. Earlier studies revealed that upon sarcomere 
contraction or stretching, the A-band length keeps constant and the edges of the H-zone 
move towards the Z disc. This observation indicates that during muscle contraction thin 
and thick filaments slide on each other (Hanson and Huxley, 1953; Huxley and 
Niedergerke, 1954; Squire, 2016). 
Later investigations of the molecular composition of thin filaments and thick filaments 
largely expanded our understanding of the contraction mechanisms. The thin filament is 
a double twisted α-helix of polymerized actin molecules. These actin filaments are 
associated with troponin complexes, which are intertwined with tropomyosin that covers 
the myosin binding sites. Muscle myosin is a hexamer composed of two heavy chains 
(MHC), two essential light chains (ELC) and two regulatory light chains (RLC) and can 
be divided into two functional domains, a globular head and a rod. Each globular head is 
composed of the N terminus of the two MHC, two ELC and two RLC. It can form a 
cross-bridge to an actin filament. It possesses actin-activated ATPase activity and is 
capable to bind to actin. The myosin rod consists of the C terminal halves of the two 
heavy chains. The C terminal end of the rod contains the coiled-coil domains and is 
involved in myosin bipolar filament assembly. Between the motor head and the rod is the 
so-called lever-arm (Clark et al., 2002). 
Introduction 
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Figure 3: Myosin cross-bridge model, modified from J. A Spudich (Spudich, 2001). See details in the text. 
In most scenarios, muscle contraction is initiated by neuronal stimulation. Upon neuronal 
stimuli, calcium channels open and release calcium from the sarcoplasmic reticulum into 
the sarcoplasm. Calcium binds to troponin, as a consequence tropomyosin moves and 
allows the myosin heads to attach to actin. Thus, the cross-bridge cycle is initiated and 
force is produced by ATP hydrolysis.  
The swinging cross-bridge model could be dissected into six steps as illustrated in Figure 
3. According to this model, the myosin head (the ATPase) spends most of its time 
detached from actin (step 1, 2). Once it is loosely attached to actin, the phosphate is 
released from the bound ADPPi and triggers the conformational change of the lever 
arm, which produces the power stroke (step 3, 4). This will move the actin filament 
towards the M line and increase the affinity between actin and myosin. This event will 
facilitate ADP release from the myosin head and enable the binding of the next ATP 
(step 5, 6). The binding of ATP to the myosin head domain will release the cross-bridge 
from the actin filament. Consequently, the ATPase of the myosin head is activated and 
induces ATP hydrolysis, which will cause a swing of the lever arm and prepare the next 
cycle. As each cycle only moves the actin filament 10 nanometers, the force generation 
for muscle contraction is a result of many of actinomyosin cycles (Geeves and Holmes, 
1999; Gordon et al., 2000; Spudich, 2001). 
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1.1.3 Regulation of muscle contraction 
In order to coordinate the complex movements of our daily life, muscle contractions have 
to be tightly regulated and finely tuned. The adjustment of muscle contraction is mostly 
reflected by the regulation of cross-bridge cycling. These regulations could be 
implemented in different ways, including the regulation of troponin complexes in skeletal 
and heart muscles, the phosphorylation of regulatory light chain by MLCK in smooth and 
heart muscle, and stretch activation in insect flight muscles (Gomes et al., 2002; Gordon 
et al., 2000; Linari et al., 2004; Ohtsuki and Morimoto, 2008; Sanders, 2008; Webb and 
Webb, 2003). 
 
Figure 4: Regulation of muscle contraction by troponin and calcium, modified from (De Oliveira Vilaca, 
2013). 
A: Tpn I blocks the myosin binding site on actin filaments and this is not dependent on Ca2+. B: Tpn C 
binds to Tpn I and release its blockage effect. C: Tpn T competes with Tpn I to bind to the Tpn I-binding 
site on Tpn C in the absence of Ca2+. In the presence of Ca2+, Tpn C undergoes a conformational switch 
and binds to Tpn I more preferably. 
1.1.3.1 Calcium and Troponin/Tropomyosin complex 
The troponin complex consists of troponin C, troponin I, and troponin T. Troponin C 
binds Ca2+, troponin I is an inhibitory component while troponin T links the troponin 
complex and tropomyosin. Troponin I binds to the actin/tropomyosin threads and 
prevents the interaction of actin with myosin in the presence of tropomyosin (Figure 4A). 
Troponin C has a high affinity binding site for troponin I and can neutralize the 
suppressive effect of troponin I in the absence of troponin T by competing the binding 
site with the actin/tropomyosin threads. This desuppression of actinomyosin interaction 
Introduction 
 7 
is independent of Ca2+ (Figure 4B). However, the existence of troponin T could prevent 
cross-bridge activation by masking the binding site of troponin I on troponin C (Figure 
4C). Thus, Ca2+ plays an essential role in this case. Upon the binding of Ca2+, troponin C 
undergoes a conformational switch and binds to troponin I in the presence of troponin T, 
thereby activating the cross-bridge cycle (Craig and Lehman, 2001; Gomes et al., 2002; 
Gordon et al., 2000; Ohtsuki and Morimoto, 2008). 
1.1.3.2 Myosin regulatory light chain 
Another regulatory mechanism involves the phosphorylation of myosin regulatory light 
chain, which can be implemented in two ways. In smooth muscle cells, increased Ca2+ 
levels activate myosin light chain kinase (MLCK) by the Ca2+-calmodulin complex, 
thereby myosin regulatory light chain (RLC) could be phosphorylated by activated 
MLCK. Phosphorylated RLC activates the ATPase of myosin and thus increases muscle 
contraction (Takashima, 2009). It has been reported that phosphorylation of regulatory 
light chain also modulate skeletal, heart, and asynchronous insect flight muscle 
contraction (Farman et al., 2009; Kampourakis et al., 2016; Szczesna et al., 2002). 
Myosin light chain phosphatase (MLCP) can dephosphorylate the regulatory light chain, 
and thus block cross-bridge cycling. Thus, Rho-kinase activation triggers muscle 
contraction by inhibiting MLCP activity. This represents the second layer of regulation, 
which is independent of Ca2+ (Webb and Webb, 2003). 
1.1.3.3 Stretch activation 
Other types of muscles such as heart and asynchronous insect flight muscles can be 
activated by mechanical stretch, which represents another layer of regulation (Campbell 
and Chandra, 2006; Moore, 2006). This mechanism is particularly profound in 
asynchronous muscles such as insect flight muscle (Pringle, 1949). Different from 
synchronous muscles that contract at a 1:1 ratio with the neuronal spikes, asynchronous 
muscle contraction is not correlated with neuronal spiking (Josephson et al., 2000). 
Furthermore, asynchronous muscle contraction is not regulated by the oscillation of 
sarcoplasmic Ca2+ levels.  
The molecular and regulatory mechanisms of stretch-activation are less well understood. 
Two hypothesizes including the helix match-mismatch hypothesis and the strain sensor 
hypothesis have been proposed to explain stretch-activation (discussed by Hooper 
(Hooper et al., 2008)). It was believed that both of them might contribute to the stretch-
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activation of asynchronous muscles. Recently, it has been shown that troponin bridges 
are involved in the regulation of stretch-activation in insect muscles. In the relaxed 
muscles, the myosin binding site on actin is blocked by tropomyosin. Upon stretch, 
troponin pulls on the troponin-tropomyosin complex and thus exposes the binding site on 
actin to the myosin head, resulting in muscle activation (Perz-Edwards et al., 2011). A 
second study showed that TnH (the larger IFM Tpn I isoform) is pulled off actin when 
the sarcomere is stretched. Tropomyosin is then released from the blocking position 
(Kržič et al., 2010). It is worth to note that in both cases, a permissive Ca2+ level is 
necessary for cross-bridges to bind to actin and to generate force. 
1.2 Drosophila muscle system 
1.2.1 Overview of Drosophila myogenesis 
The Drosophila muscle system contains multiple types of muscles with different shapes, 
positions, sizes, and functions. Precise cooperation of these muscles allows flies to walk, 
fly, mate, and feed properly. Drosophila development shows two phases of myogenesis, 
one in the embryo that builds the larval musculature important for larval locomotion and 
feeding, and a second one during pupal development that forms all adult muscles, 
including the flight muscles (Roy and VijayRaghavan, 1999). 
1.2.1.1 Drosophila embryonic body myogenesis 
As in vertebrates, the Drosophila muscle system originates from the mesoderm layer 
after gastrulation in the early embryo. Initially, a combination of intrinsic transcriptional 
regulators and extrinsic signals are important to pattern the mesoderm into distinct 
domains in each embryo segment. A combination of signaling pathways establishes 
clusters of Lethal of scute (L’sc) expressing cells, called local equivalent groups, in the 
high Twist expression domain. Within each cluster of cells, one muscle progenitor is 
segregated by sustained expression of L’sc. Subsequently, these progenitors undergo one 
asymmetrically division to generate either two muscle founder cells (FCs) or one FC and 
one adult muscle progenitor cell (AMP) (Dobi et al., 2015; Ruiz Gomez and Bate, 1997; 
Schnorrer and Dickson, 2004). Other cells of the cluster will become fusion-competent 
myoblasts (FCM). These two different types, FCs and FCMs, are the source for 
embryonic body muscle myogenesis. In contrast, the AMPs that maintain high Twist 
expression remain undifferentiated until early pupal stage. 
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After the specification of FCs, FCMs migrate to FCs and establish contact with them by 
actin-based filopodia. These contacts will initiate fusion of FCMs to FCs (Schnorrer and 
Dickson, 2004). Consequently, the fusion of myoblast increases the muscle mass and the 
nuclei number of the myotubes, which will generate the final single-fiber syncytium (the 
so-called larval muscles) (Bate, 1990). Together, this equips each abdominal 
hemisegment of the embryo with 30 body muscles with distinct sizes, positions, 
morphology, tendon attachment, and innervation patterns. 
1.2.1.2 Drosophila adult myogenesis 
The second round of myogenesis takes place at the onset of metamorphosis. Most larval 
muscles start to be histolysed and the adult muscle are built de novo. The primary source 
of the adult musculature are stem cell-like AMPs that are born in the embryo (Figeac et 
al., 2010). During larval development AMPs migrate to the precursors of the adult 
tissues, such as wing and leg imaginal discs, with which they tightly associate and 
proliferate (Bate et al., 1991). In the pupae, these AMPs fuse with each other to form the 
adult muscle fibers de novo such as leg, abdominal, or dorso-ventral flight muscles 
(DVMs). In the exceptional case of the dorsal-longitudinal flight muscles (DLMs), 
AMPs fuse to remaining larval template muscles, which have escaped histolysis (Dutta et 
al., 2004). Similar to the larval muscles, after myoblast fusion has started, the myotube 
will contact the tendons to initiate attachments. Once attached, the initial myofibrils are 
being built and they grow to their final size (Weitkunat et al., 2014). 
1.2.1.3 Drosophila adult muscle types 
Drosophila adult body muscles constitute of two major types - fibrillar indirect flight 
muscles (IFMs) powering flight and tubular body muscles required for movement of 
most other body parts, such as head, legs or abdomen (Figure 5). The Drosophila tubular 
muscles are very similar to vertebrate body muscles as they are cross-striated with 
laterally aligned sarcomeres and contract synchronously, meaning every neuronal action 
potential will cause a fiber twitch (Figure 5).  
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Figure 5: Drosophila adult muscle morphology, the fly scheme is modified from Manuela Weitkunat; The 
fibrillar and tubular muscles image are adapted from (Schönbauer et al., 2011). 
The large fibrillar DLM (green fibers), DVM (red fibers), and tubular jump muscles (blue) are present in 
the thorax. Yellow branches show the motor neurons immigrating the flight muscles. Myofibrils in tubular 
leg muscles are well aligned with each other and show a cross-striation pattern, while in fibrillar IFMs are 
not aligned. 
IFMs, the largest muscles in the thorax, are located in mesothorax and consist of two 
opposing muscle units, the DLMs and DVMs (Figure 5). Both units are not directly 
inserted at the wings but connected to the thorax, thus called indirect flight muscles. In 
sharp contrast to tubular muscles, IFMs are asynchronous muscles that utilize a stretch-
activation mechanism to contract at a high frequency, 200Hz in Drosophila. Contraction 
of the DLMs deflects thorax and via the wing hinge moves the wings down; 
simultaneously this stretches the DVMs inducing their contraction, which moves the 
wings up again, in turn stretching the DLMs. These oscillating muscle movements thus 
do not require calcium cycling, which would be extremely energy intense at this high 
contraction rate. Motor neurons fire at lower frequency during flight and Ca2+ levels stay 
elevated for the entire time of flight (Josephson et al., 2000). Furthermore, IFMs possess 
a very particular composition of contractile proteins and protein isoforms that lead to the 
characteristic fibrillar morphology. Taken together, Drosophila IFMs resemble some 
features of human heart muscles both in biomechanics and myofibril morphologies. IFMs 
are dispensable for Drosophila life, making them an excellent model to explore gene 
functions in muscle morphogenesis and function. 
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1.2.2 Development of Drosophila indirect flight muscles 
1.2.2.1 Myoblast specification 
As stated above (section: 1.2.1.1), AMPs are born as siblings of embryonic founder cells 
and characterized by persistent Twist expression (Bate et al., 1991). After the first 
asymmetric division of progenitor cells, FCs inherit Numb from the progenitor, which 
will repress Notch signaling and thus induce their differentiation. In contrast, Numb is 
not received in the AMPs, thereby Notch signaling is active and maintains Twist 
expression (Carmena et al., 1998; Ruiz Gomez and Bate, 1997). Six to seven of these 
undifferentiated AMPs in each half of the embryonic mesothoracic segment are firmly 
associated with wing disc primordial (Bate et al., 1991). These AMPs start to proliferate 
at the end of the second larval instar. One subset of these AMPs is designated to form 
IFMs, while another subset is going to build direct flight muscles (DFMs). The diversity 
of the pools of AMPs is defined by the differential expression of vestigial (vg) and cut 
(ct) (Sudarsan et al., 2001). The distal group of AMPs on the wing disc expresses high 
level of ct and low level vg is going to give rise DFMs. In comparison, the larger 
proximal subset of AMPs expresses vg and low levels of ct will contribute to IFMs. 
Interestingly, vg and ct maintain the distinction between the two groups of myoblasts in a 
mutually repressive manner (Sudarsan et al., 2001).  
1.2.2.2 Founder cell specification 
A founder cell mechanism (FCs and FCMs) for flight muscle development similar to 
embryonic somatic muscle specification has been proposed (Bate et al., 1991; Dutta et 
al., 2004; Rivlin et al., 2000). During the metamorphosis, most of the larval muscles 
undergo histolysis (~8h after puparium formation (APF)) and adult muscles such as 
DVMs are formed de novo. In the exceptional case, DLMs forms from the three larval 
oblique muscles (LOMs) in the mesothorax, which will serve as the templates to which 
AMPs will fuse. Before fusion, dumbfounded (duf) expression has been established in a 
few larger AMPs at the position where DVMs form, and in the DLM templates (Dutta et 
al., 2004). These duf expression cells are set out as FCs and low duf expression AMPs 
are designated as FCMs. Upon ablation of duf expressing FCs, myogenesis fails to occur 
properly, showing the importance of the FC concept (Atreya and Fernandes, 2008).  
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Figure 6: Developmental scheme of IFMs, adapted from Maria Spletter (M. Spletter et al., in preparation). 
FCMs migrate and start to fuse with DLM templates or DVM FCs from 8h APF. At 18h APF, both tendon 
cells and myotubes send out extensions to contact each other and establish attachment. Myotubes grow and 
compact at 30h APF, when myofibrillogenesis starts and connects the myotubes to myofibers. From then 
on, myofibrillogenesis and sarcomere maturation continues until eclosion. 
1.2.2.3 Myoblast fusion 
FCMs start to fuse with DVM FCs or DLM templates from ~8h APF until ~ 24h APF 
(Figure 6). How the FCMs fuse to DLM templates (larval LOMs) or to DVM FCs is not 
well studied. However, it is likely that similar principles governing FCMs fusion in the 
embryo are also used during adult muscle development (Schejter, 2017; Schulman et al., 
2015). In analogy to the embryonic somatic FCMs fusion, the multiple cellular events of 
the fusion process could be divided into four steps: 1) FCMs recognition and adhesion, 2) 
cytoskeleton rearrangement at the contact site, 3) fusion pore formation at the contact 
membranes 4) pore expansion and mixing of cellular components. 
Four immunoglobulin domain-containing proteins, including Dumbfounded (Duf), 
Roughest (Rst), Sticks and stones (Sns), and Hibris (Hbs), have been reported to direct 
the recognition and attraction between FCMs and FCs during embryonic myoblast fusion 
(Abmayr and Pavlath, 2012). Duf is also expressed in DLMs muscle templates while Sns 
is expressed in myoblasts. Both are essential for myoblast recognition and establishment 
of fusion sites between myotubes and myoblasts (Gildor et al., 2012). After recognition, 
SCAR/Wave and Wiskott-Aldrich Syndrome protein (WASp) activate Arp2/3 actin 
polymerization machinery at the contact site, which mediates cytoskeletal remodeling 
and thus promotes the membrane flattening and tight association at the contact site (Kim 
et al., 2015a; Mukherjee et al., 2011). This results in the formation of pores between the 
apposed membranes and thereby initiates cytoplasmic components mixing (Kim et al., 
Introduction 
 13 
2015b; Mukherjee et al., 2011). Finally, the full cytoplasmic continuity state is reached, 
which leads to the formation of the myotubes. 
1.2.2.4 Muscle tendon attachment 
At the same time as myoblasts fuse, tendon precursors are specified. Similar with 
embryonic attachment sites, tendon cells are specified by stripe (sr) (Fernandes et al., 
1996; Ghazi and VijayRaghavan, 2003). Initially, a few discrete patches of sr expression 
cells within the imaginal discs are associated with overlapping AMP. As the 
metamorphosis proceeds, these cells developed to tendon cells, which may guide the 
myotubes towards them, by possibly secreting factors (Fernandes et al., 1996). 
At about 18h APF, the growing myotubes and tendon cells send out filopodial extensions 
to contact each other and establish attachment (Figure 6) (Fernandes et al., 1996; 
Weitkunat et al., 2014). A recent study shown that Kon-tiki, a single-pass transmembrane 
protein of the neurexin family, plays essential roles during muscle tendon attachment 
establishment (Weitkunat et al., 2014). Upon knock down of kon-tiki in IFMs, the 
developing IFMs failed to recognize the tendon extensions and start to round up 
(Weitkunat et al., 2014). It is also believed that αPS1 and βPS integrin expressed in 
tendon cells as well as αPS2 and βPS expressed in the myotubes mediate attachments 
formation by forming heterodimers on the opposed cell membranes (Fernandes et al., 
1996). Interestingly, mechanical tension in the muscle tendon system increases as the 
attachment maturation proceeds (Weitkunat et al., 2014). 
Once the contact is made, it becomes smooth and stable. After attachment maturation, 
myotubes compact (Figure 6). Meanwhile, myofibrillogenesis starts and myotubes are 
converted to myofibers at 24-30h APF. Myofibrils and sarcomeres mature until 90h APF 
when the fly encloses and is ready to take off (Reedy and Beall, 1993). 
1.3 Myofibrillogenesis 
1.3.1 The models of myofibrillogenesis 
1.3.1.1 The two historical models 
Principles underlying myofibrillogenesis are not well understood. Historically, the pre-
myofibril model and the two-state model have been proposed largely based on 
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knowledge from cell culture (Holtzer et al., 1997; Kontrogianni-Konstantopoulos et al., 
2009; Ojima et al., 1999; Sanger et al., 2005; 2017). 
The first model suggests that the mature myofibrils are formed from the non-muscle 
myosin (NMHC) containing premyofibrils via by a stepwise exchange of NMHC to Mhc. 
In the premyofibrils, actin filaments are anchored to Z-bodies by α-actinin and 
interdigitate with non-muscle myosin II filaments. With the incorporation of titin and 
other myosin-binding proteins, premyofibrils mature into nascent myofibrils. At this 
stage, the Z-bodies are better aligned and the non-muscle myosin is exchanging with 
muscle myosin. Afterwards, the growth and maturation of both thin and thick filaments, 
as well as the integration of more Z-disc and M-line proteins facilitate the maturation into 
the final mature stage (Sanger et al., 2005; 2017). 
The second model proposed that the formation of I-Z-I bodies and Mhc containing thick 
filaments is more independent and both components will be assembled at the same time 
to form the sarcomere structure (Holtzer et al., 1997; Ojima et al., 1999). Before 
myofibrillogenesis, the globular-actins polymerize to form actin microfilaments and the 
myosin (including muscle myosin) assembles into bipolar myosin minifilaments through 
its C-terminal rod tail (Boateng and Goldspink, 2007). The preassembled structures such 
as minifilament precursors are prerequisite for the initiation of myofibrillogenesis in both 
models. How myofibrillogenesis is coordinated throughout the myofibers to allow 
defined myofibril initiation and sarcomere maturation is not well understood/explained 
by both models. 
1.3.1.2 A tension driven model of myofibrillogenesis 
It has been shown that contractile activation is necessary for sarcomerogenesis and 
myofibrillar organization in cultured myotubes and cardiomyocytes, indicating that 
mechanical tension in the system may be needed for sarcomere assembly (De Deyne, 
2000; Simpson et al., 1993). Indeed, in vivo studies found that myofibrils are detectable 
after the force-resistant attachment of myotubes to tendons. Moreover, tension is built up 
before myofibrillogenesis is initiated (Weitkunat et al., 2014). Importantly, 
compromising the tension buildup ether by laser-cutting or genetic manipulation 
abolished correct myofibrillogenesis, indicating that tension build up and 
myofibrillogenesis are coupled processes (Weitkunat et al., 2014; 2017). Based on these 
findings and previous knowledge, Schnorrer and colleague proposed a novel tension 
driven model of myofibrillogenesis (Lemke and Schnorrer, 2016). In the initially stage, 
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both ends of myotubes are attached to tendons and tension is built up to orient as well as 
organize the assembly of the actin and myosin filaments across the whole myotubes 
(Figure 7A). Subsequently, addition of core sarcomeric components such as muscle 
myosin and titin to myofibrils increases tension in the system and stimulates the self-
organization of periodic immature myofibrils (Figure 7B). At the later stage, more 
myosin, titin, and α-actinin are added to the periodic immature myofibrils, which leads to 
the sarcomere maturation as the tension driven self-organization proceeds (Lemke and 
Schnorrer, 2016; Weitkunat et al., 2014; 2017) (Figure 7C). This newly formatted 
hypothesis perfect explains why sarcomerogenesis proceeds simultaneously throughout 
the entire large muscle fiber. 
 
Figure 7: A tension driven myofibrillogenesis model in Drosophila, modified from (Lemke and Schnorrer, 
2016). 
A: Dynamic actin filaments at 18h APF when tension is low. B: At 30h APF, muscle tendon attachment 
matured and the tension in the tissue is high. B: Immature myofibrils assemble simultaneously to span the 
entire fiber. Note that at this stage, sarcomere structure is still immature. C: Large amounts sarcomeric 
structural components are incorporated into the existing immature sarcomeres. 
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1.3.2 Myofibril and sarcomere maturation in Drosophila IFM 
After muscle tendon attachment immature myofibrils contain periodic pattern of α-
actinin, obscurin, and kettin at 30h APF (Orfanos et al., 2015; Weitkunat et al., 2014) 
(Figure 7A, 7B). At this stage (30h APF), the immature sarcomeres are about 1.8 µm in 
length. From then on, the sarcomeres need to mature and continues to grow to 3.2 µm in 
length and reach a diameter of 1.5 µm in the adult IFM (Orfanos et al., 2015). And 
interestingly, the number of myofibrils (~2000) in one fiber keeps constant during 
sarcomere maturation stage, although the length of myofibrils and the volume of fibers 
grow dramatically during this period (M. Spletter, X. Zhang and F. Schnorrer in 
preparation). Strikingly, all myofibrils and sarcomeres mature synchronously in both 
fibrillar IFMs and tubular abdominal muscles (Weitkunat et al., 2014; 2017). A recent 
study showed that simultaneously growth of sarcomere is realized by incorporating actin 
monomers and short filaments to the existing thin filaments actively (Shwartz et al., 
2016).  
Collectively, these data suggest that the sarcomere maturation is involved in 
synchronously adding of components, including actin filaments and thick filaments, to 
the immature sarcomere. However, the detailed mechanisms of sarcomere maturation and 
its transcriptional regulation as well as the coordinated addition of components to all the 
sarcomeres simultaneously remain to be explored. 
1.4 Transcriptional regulation of IFM specification 
and differentiation 
Multiple transcription factors and signaling pathways were shown to be involved in the 
regulation across all the steps of myogenesis (reviewed in (de Joussineau et al., 2012; 
Dobi et al., 2015)). Although a number of key identity genes have been extensively 
studied in Drosophila embryonic myogenesis, little progress was made until recently in 
adult muscles. How transcription factors instruct the formation of myofibrils and 
sarcomeres, in particular, how they instruct differently in the different muscle types is 
poorly understood. IFMs, a fibrillar Drosophila adult muscle, serve an ideal model to 
answer these questions. 
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1.4.1 Mef2 - A general factor 
Myocyte Enhancer Factor-2 (Mef2), a MADS domain transcription factor, plays central 
role during vertebrate muscle differentiation (Black and Olson, 1998). Studies in 
Drosophila myogenesis indicate a function during both embryonic and adult myogenesis 
(Bour et al., 1995; Bryantsev et al., 2012a; Cripps et al., 1998; Ranganayakulu et al., 
1995; Soler et al., 2012). After AMPs specification, FCMs fuse with FCs or DLM 
templates to initiate differentiation. Before IFMs differentiation, Mef2 is inhibited by 
Twist through its target Holes in muscle (Him) in myoblasts (Soler and Taylor, 2009). At 
the onset of myoblast fusion (8h APF), Vg mediated repression of Notch signaling down-
regulates Twist, thus its inhibitory effect on Mef2 is released, which promotes myoblasts 
and IFMs differentiation (Bernard et al., 2006). Interestingly, upon differentiation, 
elevated Mef2 levels activate Vg expression via an 822bp vestigial adult muscle 
enhancer (AME) (Bernard et al., 2009). When Mef2 is depleted during early stages of 
fusion, myoblasts migrate to myotubes normally but fail to fuse (Bryantsev et al., 2012a). 
Furthermore, reduced expression levels of Mef2 at later stages do not affect the formation 
of myofibers, but myofibers shown perturbed integrity and severe defects in myofibril 
organization (Bryantsev et al., 2012a; Soler et al., 2012).  
Taken together, Mef2 plays essential functions at different stages including initial 
myoblast and myotube differentiation, as well as myofibril maturation (Bryantsev et al., 
2012a; Soler et al., 2012). However, Mef2 binds to pan-muscular-enhancers and many 
structural gene enhancers, acting as a general factor important for most if not all muscle 
types. Hence, fibrillar IFMs acquire their specific properties by additional transcriptional 
regulation. 
1.4.2 Identity genes of IFM patterning and differentiation 
1.4.2.1 Spalt major (Salm) 
In a genome-wide RNAi screen for genes required for adult myogenesis, numerous 
genes, including transcriptional regulators and structural components, essential for IFMs 
development have been identified (Schnorrer et al., 2010). Among them, salm, a zinc 
finger transcription factor, has been identified as a fibrillar flight muscle specific selector 
gene (Schönbauer et al., 2011). salm is specifically expressed in IFMs after myoblast 
fusion, and salm known-down switches IFM from fibrillar morphology to tubular 
morphology. When ectopically expressed in leg muscle, salm induces a switch from 
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tubular to fibrillar fate. This indicates that salm is not only required but also sufficient to 
induce fibrillar flight muscle fate in Drosophila. The role of Salm is conserved across 
most insects, thus, salm is a myofibril selector gene across 300M years of evolution 
(Schönbauer et al., 2011). Interestingly, vg, another transcription factor expressed in IFM 
forming myoblasts is required for salm expression in myotubes, thus playing a role 
upstream of salm (Bernard et al., 2003; Schönbauer et al., 2011) (Figure 8). 
 
Figure 8: Transcriptional cascade of IFM specification 
Exd, hth, and vg locate upstream of salm and positively regulate salm expression, while exd and hth also 
induce the expression of a subset of fibrillar muscle specific genes. Salm is required and sufficient to 
induce fibrillar muscle fate as well as to repress tubular muscle fate. Aret, a downstream target of salm, 
regulates alternative splicing of a subgroup of fibrillar sarcomeric gene isoforms. 
1.4.2.2 Extradenticle (Exd) and Homothorax (Hth) 
A later study from Cripps lab showed that two homeodomain proteins, Extradenticle 
(Exd) and Homothorax (Hth), are also required to determine fibrillar muscle fate 
(Bryantsev et al., 2012a). They are both expressed in developing IFMs and other body 
wall muscles except the jump muscles from the myoblast stat onwards, while salm is 
mainly expressed in IFM forming myotubes (Bryantsev et al., 2012b; Schönbauer et al., 
2011). It has been shown that exd and hth activate the expression of flight muscle 
specific structural genes such as Actin88f and flightin (fln), and repress the expression of 
TpnC41C, a jump muscle specific structural gene (Bryantsev et al., 2012b). It is worth to 
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note that vg, exd and hth function genetically upstream of salm (Figure 8). Except these 
selector genes, E2F, a cell cycle transcription factor, also has been shown to directly 
regulate IFMs specific gene transcription (Zappia and Frolov, 2016). 
1.4.3 The downstream targets of Salm 
During embryonic myogenesis, identity genes have been shown to specify muscle fate by 
regulating downstream genes essential for different aspects of muscle development 
(Tixier et al., 2010). The same is true for fibrillar IFM development. By microarray 
analysis, hundreds of fibrillar muscle specific genes, including the known stretch 
sensitive genes fln, Myofilin, Stretchin-Mlck (Strn-mlck), and TpnC4, were found to be 
significantly downregulated in salm knockdown IFMs (Schönbauer et al., 2011). 
Conversely, many body wall muscle specific proteins such as MP20 and TpnC41 are 
upregulated (Schönbauer et al., 2011). Notably, exd and hth need to collaborate with 
salm to regulate many of these IFM specific genes expression (Bryantsev et al., 2012b; 
Schönbauer et al., 2011). The microarray study also suggested that salm not only 
regulates its targets transcriptionally but also changes alternative splicing. This was 
systematically investigated by mRNA-seq analysis, which identified a core group of 
about 700 fibrillar specific gene isoforms are regulated by salm (Spletter et al., 2015). 
Thus, salm regulates IFM fate determination and differentiation by differential 
transcription and splicing. 
Although some targets of Salm have been found, it is unclear if Salm binds to the 
enhancers of these genes directly and how it collaborates with Mef2. Moreover, as 
discussed above (1.3.2 and 1.3.3) myofibrillogenesis occurs in two stages, namely 
myofibrillogenesis initiation and sarcomere maturation, during Drosophila IFM 
development. Does Salm regulate these two stages directly or by its downstream 
transcription factors? To gain insights about the underling mechanism of transcriptional 
regulation, it is necessary to identify direct targets of Salm in IFMs. However, it is 
difficult to collect enough fresh and pure myotube material and to obtain high quality 
antibodies for genome-wide analysis, such as ChIP-seq studies in a tissue and stage 
specific manners. Thus, establish precise genome editing method to tag the endogenous 
salm locus is important, which enable one to use commercially available high quality 
antibodies. 
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1.4.4 Splicing regulation during IFM development 
aret (also called Bruno), a Drosophila orthologue of vertebrate CELF (CUG-binding 
protein and ETR-3–like factor) RNA-binding protein, has been suggested as a potential 
salm target by microarray data analysis. This has been confirmed by two recent 
investigations which found that aret is directly involved in the regulation of IFMs 
specific protein isoforms splicing such as Strn-Mlck and Tpn I (Oas et al., 2014; Spletter 
et al., 2015). Knockdown of aret in IFMs disrupt the myofibril maturation process 
largely after 48h APF. At 72h APF, the sarcomere length is significantly shorter 
compared to wild type. The aret mutant IFM fibers hypercontract resulting muscle 
atrophy at the adult stage (Spletter et al., 2015). These results showed that post-
transcriptional regulation also plays an essential role during IFM sarcomere maturation. 
Interestingly, it has been shown that in vertebrates, both transcriptional regulation and 
alternative splicing are extensively involved in muscle fiber specification (Spletter and 
Schnorrer, 2014). However, how the defective sarcomere maturation caused by 
misregulated transcriptional program is not clear. 
1.5 IFMs as a model to study human muscle 
hypercontraction 
1.5.1 Conservation of muscle biology from fly to human 
Compared with the single-fiber embryonic muscles, Drosophila adult muscles are 
composed of multiple fibers, which resemble vertebrate skeletal muscles and make it a 
more attractive model for vertebrate muscle development. Despite the overall difference 
between vertebrate skeletal muscle and Drosophila flight muscle, many developmental 
and functional aspects are conserved.  
First, patterning and regulation of muscle development in both systems are particularly 
well conserved (summarized by Taylor (Taylor, 2006)). 
Second, the functional core complexes (actin/troponin-tropomyosin, titin and myosin) 
and their arrangement in both Drosophila adult muscles and human muscles are very 
similar. And not surprisingly, they share a common contracting mechanisms: the filament 
sliding and myosin swinging cross-bridge model (Hooper and Thuma, 2005; Hooper et 
al., 2008). 
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Moreover, Drosophila adult flight muscles are dispensable for life, which allows the 
investigation of null mutations. With this system, using the large body of genome-wide 
resources, it is easier to genetically manipulate them, compared to vertebrate models. 
Biological research in Drosophila showed its large potential in unraveling vertebrate 
development in normal and pathological conditions (Ugur et al., 2016; Wangler et al., 
2015). Thus, studying Drosophila adult muscle development will likely impact vertebrate 
muscle biology.  
1.5.2 Model for muscle hypercontraction 
Distal arthrogryposis (DA) syndromes are rare and complicated congenital diseases 
characterized by uncontrolled distal limb joint contractures. They are often associated 
with congenital myopathies (Kimber, 2015). Interestingly, several DA subtypes have 
been identified as a consequence of mutations in genes encoding sarcomeric proteins 
such as β-tropomyosin (TPM2), fast troponin I (TNNI2), fetal myosin heavy chain 
(MYH8), fast troponin T (TNNT3), embryonic myosin heavy chain (MYH3), and slow 
skeletal muscle myosin binding protein C (MYBPC1) (Gurnett et al., 2010; Kimber et al., 
2006; Sung et al., 2003; Tajsharghi et al., 2007; Toydemir et al., 2006a; 2006b). 
Strikingly, these DA-associated mutations in TPM2, TNNI2, and TNNT3 all display 
elevated muscle contractility and produce muscle hypercontraction (Robinson et al., 
2007). These results explain why myopathies are usually observed in DA patients. It is 
worth to note that a MYBPC1 mutation also has been detected in another subtype of 
arthrogryposis called lethal congenital contractural syndrome (LCCS) (Markus et al., 
2012). Thus, it appears that the multiple contracture phenotype results from the 
uncontrolled force caused by misregulated actinomyosin machinery during muscle 
development in humans. 
A series of mutations in sarcomeric actinomyosin components are known in flies. Some 
of these are associated with muscle hypercontraction, a phenotype characterized by 
normally developed IFMs which undergo excessive contractions causing muscle damage, 
muscle detachment, and subsequent muscle atrophy (Nongthomba et al., 2003). 
Mutations in IFMs specific isoforms of Tpn I or Tpn T can lead to muscle 
hypercontraction and subsequently muscle detachment or muscle fiber tearing in the 
middle of the fibers (Nongthomba et al., 2007; 2004). At the sarcomere level, the IFMs 
display Z disc and M-line disorganization and so-called zebra-bodies, which are actin 
accumulations. Furthermore, mutations in the fly single muscle myosin heavy chain Mhc 
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gene, which reside in the ATPase domain (Mhc6 and Mhc13) also have been reported to 
cause IFMs hypercontraction (Montana and Littleton, 2004). 
In summary, as the core components of the sarcomere are highly conserved from 
Drosophila to human, studying the function of these proteins during IFM development 
may gain mechanistic insights into the pathologies of human muscle diseases.  
1.6 Genetic Drosophila resources 
1.6.1 RNAi libraries, Fosmid libraries, and MiMiC 
collections 
In the past genomic era, remarkable efforts have been put into the development of 
genome-wide approaches and resources. This led to the generation of the first Drosophila 
genome-wide transgenic RNAi library (Dietzl et al., 2007). Meanwhile, additional RNAi 
libraries including NIG-FLY and TRiP were created (summarized in (Kaya-Çopur and 
Schnorrer, 2016)). These resources largely expanded the systematic assessment of gene 
function. One such genome-wide tissue-specific screen was performed in Drosophila 
muscle and identified numerous novel players important for muscle development and 
function (Schnorrer et al., 2010). Among these, Salm has been identified as a conserved 
identity gene for IFM development in insects (Schönbauer et al., 2012). Another well-
established example is Aret, which also has been confirmed an important function during 
IFM differentiation (Spletter et al., 2015). Apart from these, several interesting candidate 
genes, including CG11617, CG17912, and CG32121, have been found to be specifically 
expressed in Drosophila body muscles (Sarov et al., 2016). Their functions are still 
waiting to be confirmed with mutants. 
The next step after the discovery of a candidate gene is a mechanistic characterization of 
its function. Usually, the first step is to define the particular expression and subcellular 
localization of the candidate protein. However, due to lack of specific antibodies or live 
visualization probes, it is time consuming to make antibodies or tag the gene of interest 
with traditional methods. Thus, two collections of protein tag libraries have been 
established in flies: a Minos Mediated Integration Cassette (MiMIC) collection and a 
Fosmid collection (Nagarkar-Jaiswal et al., 2015; Sarov et al., 2016; Venken et al., 
2011). MiMIC applied a genome-wide mutagenesis by a minos transposon mediated 
insertion of a cassette carrying a dominant marker and STOP cassette flanked by two 
integrase attP sites. Upon insertion, within an intron the termination signal followed the 
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splicing acceptor sequence in the cassette terminates transcription resulting in a loss of 
function allele. By ΦC31 integrase mediated cassette exchange, the termination cassette 
can be exchanged with any DNA of interest. This smart design allows versatile genome-
manipulation such as creating a protein-trap line for studying protein localization. One 
important limitation for the MiMIC system is that the insertion position is random, thus 
the insertion may affect protein function and not all genes of the genome are accessible. 
To complement this limitation, a strategy with high gene coverage and defined tag 
position would be preferable. The fosmid library combines recombineering approaches to 
tag a large Drosophila genomic DNA fragment in bacteria, with ΦC31 integrase 
mediated transgenesis into a defined locus to generate transgenic Drosophila lines 
(Ejsmont et al., 2009). With this approach, a comprehensive genome-wide fosmid 
constructs library including about 10,000 C-terminal tagged proteins or protein isoforms 
clones, has been created. These clones were used to generate more than 800 transgenic 
lines and about 200 tagged proteins have been tested for their expression and cellular 
localization pattern in vivo (Sarov et al., 2016). The results showed a impressive potential 
for using fosmid lines to investigate protein expression and localization pattern, as well 
as protein-protein interaction, and protein dynamics with live imaging. 
1.6.2 Precise genome editing methods: TALENs and CRISPR 
The development of precise genome-editing methods significantly boosted the study of 
reverse genetics in recent years by allowing locus specific gene targeting. In order to 
fully explore the function of novel genes, it is necessary to modify the endogenous gene 
locus. However, it is relatively tedious to engineer a specific gene with traditional 
homologous recombination approaches in flies. The recent development of Transcription 
Activator-like Effector Nucleases (TALENs) and Clustered Regularly Interspaced Short 
Palindromic Repeats (CRISPR) technologies in other model organisms provide potential 
ways to improve the gene targeting in Drosophila. 
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Figure 9: Schematic representation of TALEN or CRISPR/Cas mediated genome engineering. 
TALEN or Cas9-sgRNA complex bind to DNA and induce DSBs at the designed position. For Cas9 
induced cut, a PAM sequence is necessary to allow Cas9-sgRNA complex to unwind the genome. The 
generated DSBs will be repaired either by error-prone NHEJ pathway or by HDR in the presence of 
homology donor sequence. The latter enables precise genome editing. 
TALENs originate from naturally occurring transcription factors present in plant 
pathogens called TALEs. They are built of 12–27 repeats, each typically containing 34 
amino acids. Each repeat binds to a specific base pair of DNA, which is determined by a 
di-residue within the repeat. The C-terminal transcriptional activator of TALEs has been 
replaced with a FokI nuclease domain, converting it to a sequence specific nuclease 
(Barrangou, 2013; Joung and Sander, 2012). Since the FokI nuclease is active as a dimer, 
TALENs are designed in pairs binding to opposite DNA strands (Figure 9). The double 
strand breaks (DSBs) generated by TALENs are repaired by non-homologous end 
joining (NHEJ) or by homology directed repair (HDR) in the presence of homologous 
sequences (Figure 9). NHEJ usually introduces small insertions or deletions and thus 
causes mutations, while HDR is a precise repair, which can be used for precise gene 
tagging (Joung and Sander, 2012). TALENs had been applied to several organisms 
including Arabidopsis, zebrafish, and mice, to mutate or tag genes but not yet to 
Drosophila when this work was initiated (Cermak et al., 2011; Sung et al., 2013; Zu et 
al., 2013).  
Most recently, the application of CRISPR/Cas9 system for gene targeting is booming, 
largely promoted by its simple design and high efficiency to introduce DSBs. 
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CRISPR/Cas9 is a RNA-guided DNA endonuclease from Streptococcus. pyogenes. It can 
form a complex with single strand guide RNA that is designed to bind to specific genome 
sequences. A Protospacer Adjacent Motif (PAM) locates at the 3’ end of the targeting 
sequence is required for Cas9-sgRNA complex to interrogate into the DNA (Sternberg et 
al., 2014). Once the complex binds to the genome, it cuts the targeting region and 
induces DSBs that can be repaired similarly as the TALENs generated DSBs. Thus 
CRISPR can also be utilized to mutate or tag a gene (Figure 9). CRISPR/Cas has been 
successfully used in yeast, eukaryotic cells, mice, as well as zebrafish and was 
successfully applied to Drosophila in the course of this work (Bassett et al., 2013; Cong 
et al., 2013; Dicarlo et al., 2013; Gratz et al., 2013; Hwang et al., 2013; Wang et al., 
2013).  
1.7 Aims of the thesis 
In this work, I aimed to establish precise genome-editing methods in Drosophila 
melanogaster and then applied them to dissect the function of genes involved in 
Drosophila IFM development. 
First, I planed to establish and use TALEN to mutate candidate genes (salr, CG11617 
and CG32121) from our RNAi screen. 
Second, I aimed to establish CRISPR/Cas and employ it to mutate CG32121 (which we 
called Fallen Angel, fall), to tag fall, and to generate different gene variants for structural 
function study. I also planed to apply CRISPR to tag salm at its N-terminus and C-
terminus with different tags for the ChIP-seq experiment in the future. 
Third, I wanted to characterize the phenotype of fall mutants, the expression of Fall, the 
molecular function of Fall protein domains, and its role in IFM during development 
especially during sarcomerogenesis. 
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2 Discussion and Outlook 
2.1 Establishment of precise genome editing 
methods in Drosophila 
The emergence of TALENs and CRISPR mediated genome modifying methods 
revolutionized our view of genome editing. Shortly after the pioneering publications, 
these methods have been adapted to several model organisms and showed their potential 
for human gene therapy (Doudna and Charpentier, 2014; Hsu et al., 2014; Mendell and 
Rodino-Klapac, 2016; Themeli et al., 2015).  
2.1.1 Applications of TALENs in Drosophila 
We have successfully established TALENs induced mutagenesis in Drosophila at the 
same time as other labs (Katsuyama et al., 2013; Zhang et al., 2014a). Null mutants of 
our candidate genes from the RNAi screen, including CG32121, CG11617, and spalt 
related, have been generated. Surprisingly, CG11617 and spalt related null alleles did 
not give any obvious phenotype in IFM (X. Zhang and F. Schnorrer unpublished data), 
while fall mutant displayed a severe defect during IFM development. In our hand, we 
used TALENs to generate specific gene knockout with a relative high efficiency (up to 
~10% mutagenesis per fertile G0 cross) (Zhang et al., 2014a).  
However, we have not been successful in integrating a GFP tag by HDR despite testing 
several conditions (unpublished results). This was likely due to the limitation of our 
PCR-based detection method of the rare HDR event. In other studies, only a few genes 
with visible phenotypes, which enable a very simple identification of the targeted 
animals, have been targeted by HDR (Katsuyama et al., 2013; Liu et al., 2012). These 
observations indicate that the HDR efficacy would need further optimization in order to 
effectively tag or manipulate genes systematically. Moreover, the tedious assembly of 
TALEN pairs is an obvious disadvantage compared with CRIPSR/Cas (Cermak et al., 
2011). 
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2.1.2 CRISPR/Cas9 
2.1.2.1 General applications of CRISPR/Cas9 in Drosophila 
Compared with TALENs, the CRISPR/Cas9 system only requires one single strand guide 
RNA (sgRNA) and the presence of the Cas9 nuclease to cut genomic DNA at a defined 
position (Cong et al., 2013). Several algorithms provided online facilitate the design of 
sgRNAs including the one that we have used from the Feng Zhang lab 
(http://crispr.mit.edu/). In Drosophila, multiple strategies have been designed for 
customized applications based on CRISPR/Cas9 systems (Bassett et al., 2013; Gratz et 
al., 2013; Zhang et al., 2014b). The simplest application, generation of gene knockout, 
has been implemented in several publications with high efficiency. The CRISPR/Cas9 
generated indels can be easily identified with various methods, including the T7 
endonuclease assay that we applied, High-Resolution Melt Analysis (HRMA), and 
surveyor nuclease assays (Bassett et al., 2013; Cong et al., 2013; Zhang et al., 2014b). By 
applying a selection marker, the identification of germline genome editing events is 
strongly simplified. Another application is locus specific insertion of DNA elements such 
as tag sequences, an attP sequence, or an FRT site, which enables sophisticated 
subsequent gene modification (Gratz et al., 2014; Zhang et al., 2014b). These insertions 
can also be identified by T7 endonuclease or surveyor nuclease assays. However, the 
frequency for DNA insertion events is much lower compared to small deletions and thus 
demand more work for identification. A dominant selection marker is preferred to 
simplify the identification of targeting event. 
2.1.2.2 Combination of CRISPR/Cas with RMCE 
In many scenarios, researchers want to study their favorite genes in detail, requiring 
various alleles. This often requires to knockout the gene, and subsequent characterization 
of its expression and localization pattern. Frequently, a conditional allele would be very 
insightful. To provide a solution to this problem, we have combined CRISPR with the 
MiMIC technologies to generate a versatile two-step strategy that enables multiple 
aforementioned applications (Zhang et al., 2014b) (Figure 10). First, we apply CRISPR 
to insert a modified MiMIC cassette bearing a dsRed selection marker, which largely 
simplified the identification of successful insertion events, and STOP cassette into a 
specific targeting site (Figure 10B). In the second step, recombinase-mediated cassette 
exchange (RMCE) by the ΦC31 integrase allows to insert any DNA sequences to the 
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desired locus (Figure 10C). The successful exchange event can be easily found by 
screening the loss of dsRed marker. We have successfully used this method to tag salm at 
both its N and C-terminus with various tags (Zhang et al., 2014b). 
 
Figure 10: CRISPR-RMCE based strategy for genome editing. 
A: A selection cassette bearing a 3P3-dsRed eye marker and two attP sites. B: CRISPR mediated cassette 
insertion event can be easily identified by dsRed marker screening in flies. C: ΦC31 integrase mediates 
cassette exchange; successful exchange is identified by non-dsRed flies screening. In this step, any 
customized DNA sequence can be inserted into the locus of interest. 
We have been able to delete mostly the entire CG32121 gene, which we then called 
fallen angel (fall), and have exchanged back different truncated variants, which allow 
subsequent structural function characterization, into the fall-dsRed locus by RMCE. In 
our lab, we have targeted several loci with the CRISPR-RMCE strategy and obtained an 
efficiency up to 38% per fertile G0 cross (X. Zhang and F. Schnorrer in preparation). 
Moreover, a 18kb genomic region has been successfully deleted with a comparable 
efficiency (M. Spletter and F. Schnorrer unpublished data), showing that CRISPR-
RMCE is a versatile tool for genetic manipulation in Drosophila. 
However, we are aware of the fact that leftover sequences such as attR and FRT sites 
may interfere with endogenous transcription or splicing regulation and thereby disrupt 
normal transcription or alternative splicing. From our experience, choosing the targeting 
site wisely can circumvent this problem. However, one could also use the so-called 
scarless strategy by putting the selection marker in between two piggyBac transposon 
sites, which can be removed later with almost no leftover sequences (Fei Xie, 2014). In 
conclusion, CRIPSR/Cas9 is highly efficient and flexible to create knockout and knockin 
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alleles.  In combination with RMCE, it enables efficient gene targeting and structural 
function studies of the endogenous locus of Drosophila genes in the future. 
2.2 Fallen angel (fall), a novel BTB-ZF 
transcription factor, is essential for sarcomere 
growth and maturation 
2.2.1 The fall loss-of-function phenotype 
2.2.1.1 fall loss-of-function flies are viable but flightless 
With TALENs and CRISPR mutations in CG32121, which we called fall[1] and fall[2] 
were generated. In fall[1], the sequences between the second intron and the end of the 
second coding exon were deleted, while in fall[2] except the first small exon, all other 
parts of the gene have been deleted. Both fall[1] and fall[2] are homozygous viable and 
flightless. In the adult flies, flight muscles undergo atrophy. Detailed analysis showed 
that this muscle defect arises at around 56h APF during sarcomere growth. In the fall 
mutants, the myofibrils contain shorter sarcomeres. These observations indicate that Fall 
is dispensable for the viability but essential for sarcomere growth and maturation during 
flight muscle development. 
2.2.1.2 Sarcomere maturation defect and hypercontraction in fall 
mutants 
In both fall[1] and fall[2] homozygous alleles or over a large fall deficiency, IFMs 
undergo muscle atrophy during development with most IFMs degenerating until adult 
stage. In fall[1], tendon cells rupture happens at 56h APF. The MTJ in fall[1] appears 
morphologically normal and β-PS integrin localization was not affected prior to rupture. 
Furthermore, MTJ reinforcement could not prevent the rupture in tendon cells. However, 
loss of force in the Mhc[10] (Cripps et al., 1994) allele rescued the tendon rupture 
phenotype. These data indicate that fall[1] IFMs produce higher force than the tendon 
cell can withstand, resulting in their rupture. 
In fall[2], muscle tearing in the middle of the myofiber, a characteristic of muscle 
hypercontraction, is the predominant phenotype. The sarcomere morphology in fall[2] is 
affected more severely compared with fall[1]. Interestingly, the muscle fiber tearing 
phenotype in fall[2] is also rescued by Mhc[10].  
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Taken together, in both alleles, sarcomerogenesis is disrupted at the sarcomere 
maturation stage. This induces higher force in the muscle-tendon system that likely 
exceeds normal levels, leading to hypercontracted muscle and muscle or tendon ruptures. 
The force in fall[1] muscle fibers might be higher since the myofibrils retained a better 
structure compared with fall[2] before rupture. This may explain why the rupture occurs 
within tendon cells in fall[1] while the muscle fibers rupture in fall[2].  
 
Figure 11: Transcriptional regulation of sarcomere maturation. Mef2 is essential for all stages of IFM 
development. Hth, Exd, and Salm are known specify IFM fate. Aret is a Salm target and involved in 
sarcomere maturation. Fall is a novel transcription factor that regulates sarcomeric structural genes 
expression during maturation stage. 
2.2.2 Fall regulates the transcription of sarcomeric genes 
2.2.2.1 Fall is a transcriptional regulator  
By comparing the mRNA profile of wild type with fall[1] mutant IFMs at 48h APF, 
hundreds of misregulated genes have been identified. Moreover, proteomics data showed 
high correlation with these RNA-seq results, confirming the RNA sequencing data. In 
contrast, the DEXSeq analysis did not show an obvious splicing defect in fall[1]. Thus, it 
is likely that Fall binds to DNA directly and regulates transcription (Figure 11), similar 
as many other BTB-ZF proteins do. Notably, clustering analysis of RNA-seq discovered 
that misregulated genes in fall[1] are enriched in a particular gene clusters that is 
upregulated during the sarcomere maturation phase (cluster 22) (M. Spletter, X. Zhang 
and F. Schnorrer in preparation) (Figure 11). Genes in this cluster, regulated by Fall, 
include Zasp52, Zasp66, Unc-89, starvin (stv), Formin homology 2 domain containing 
(Fhos), sarcomere length short (sals), fln, IFM specific isoform Strn-Mlck, and the titin 
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homolog sallimus (sls), which are abundant and essential components for sarcomere 
maturation during IFM development (Figure 11). Strikingly, all of them are 
downregulated in fall[1] compared with wild type at 48h APF, suggesting a defect during 
sarcomere maturation in fall mutants. This is consistent with normal initiation of 
myofibrillogenesis in fall mutants. However, these immature sarcomeres failed to mature 
properly, resulting in hypercontraction and muscle atrophy. These data let us to propose 
that Fall is an essential transcription factor that specifically involved in sarcomere 
maturation stage (Figure 11). 
2.2.2.2 Sarcomere maturation defect and hypercontraction might be 
caused by misregulation of Fall targets 
Integrated analysis of RNA-seq and proteomics data showed that the tubular muscle 
specific TpnC (TpnC47D and TpnC25D) and ubiquitously expressed TpnC73F (Herranz 
et al., 2004) are upregulated while the IFM-specific TpnC (TpnC4) (Feng et al., 2003) is 
downregulated in IFMs of fall mutants. The misregulation of TpnC isoforms may lead to 
altered troponin/tropomyosin complex dynamics or Ca2+ regulated muscle contraction, 
and thereby influence actinomyosin activity resulting in hypercontraction. In addition, 
the expression of Strn-Mlck, a potential myosin light chain kinase, is almost lost in both 
fall[1] and fall[2]. It has been shown that this IFM specific isoform of Strn-Mlck 
localizes to thick filament and causes IFM hypercontraction upon RNAi knockdown 
(Spletter et al., 2015). Thus, fall mutation induced hypercontraction might be caused by 
the misregulation of its potential target genes such as TpnC4 and IFM specific Strn-Mlck.  
Furthermore, in wild type, expression of many essential structural genes is induced at 48h 
APF, in order to produce large amounts of proteins for correct and fast sarcomere growth 
and maturation. In fall mutant, this induction failed to occur, which may lead to 
sarcomere growth arrest or uncoordinated sarcomere assembly and thus changing the 
tension balance in muscle tendon system. Taken together, the disrupted actinomyosin 
activity as well as perturbed sarcomere growth is likely caused by the misregulation of 
Fall targets and leads to muscle hypercontraction during IFM development. 
Interestingly, flies bearing mutations in the troponin complex (TpnI, TpnT, and TpnC) 
and several dominant myosin alleles such as Mhc6 and Mhc13 displayed a specific 
hypercontraction (hypercontracture in vertebrate) phenotype in IFM during development 
(see introduction section 1.5), which is characterized by hypercontracted muscle fibers, 
shortened sarcomeres, and muscle rupture, resulting in muscle atrophy. Moreover, a 
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more recent publication suggests that the Ca2+-dependent spontaneous contraction is 
crucial for sarcomerogenesis in Drosophila skeletal muscle (Weitkunat et al., 2017). 
These results and our own data suggest that tightly regulated actinomyosin activity is 
essential for correct sarcomerogenesis and disruption of actinomyosin activity may lead 
to muscle hypercontraction during development. 
2.2.3 Fall expression and localization pattern 
2.2.3.1 Body muscle specific Fall expression and function 
The C-terminally tagged Fall-GFP Fosmid line completely rescued the muscle 
morphology and flight phenotype of fall[1] and fall[2]. This showed the specificity of 
the Fall loss-of-function phenotype and validated that Fall is required to prevent IFM 
atrophy. It also suggests that C-terminal tagging of Fall produces a functional Fall 
protein, which is also supported by the fall-CDS-HA insertion in the endogenous fall 
locus that restored the Fall function. However, a small N-terminally tag prevented the 
entry of Fall into the nucleus in S2 cells (unpublished observation). Together, this 
indicates that the C-terminal tagging retains Fall function while N-terminal tagging may 
interfere with a potential nuclear localization signal.  
Both Fall-GFP Fosmid and Fall-HA endogenous tag showed that Fall is expressed in 
nuclei of all body muscles of the fly but not in visceral muscle. However, muscle 
atrophy, resulting from fall mutation only manifested in flight muscles (DVMs and 
DLMs) but not jump, leg, and abdominal muscles. fall null mutants are fully viable, even 
when aged for weeks, suggesting that Fall is not essential for muscle function in general. 
In addition, flight muscle specific expression of Fall with Actin88f>GAL4 (high 
expression starts at 18h APF during IFM development) in the fall mutation background is 
sufficient to completely restore IFMs morphology. These data strongly suggest that Fall 
has a specific function in IFM development but not in other body muscles. Interestingly, 
rescue of the fall phenotype with Fln>GAL4 (high expression starts after 48h APF during 
IFM development) was not successful, indicating an early requirement of Fall expression 
for sarcomere maturation. 
2.2.3.2 Fall localises in nuclear body pattern in IFM 
Fall expression in IFMs is detectable from 34h APF and reaches high levels at 48h APF. 
The protein localizes to the nuclei, where it displays multiple discrete small dots or 
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speckles, some of which have been characterized as a biophysical liquid-liquid phase 
separation (Zhu and Brangwynne, 2015). This localization pattern is distinct from PML 
bodies, P bodies, and Cajal bodies but resembles nuclear speckles, paraspeckles, and 
insulator bodies pattern (Gómez-Díaz and Corces, 2014; Mao et al., 2011). Nuclear 
speckles and paraspeckles have been found to play roles in pre-mRNA splicing and A-to-
I editing (Mao et al., 2011). Previous work found that upon transcriptional inhibition by 
applying actinomycin D to cell culture, both nuclear speckles and paraspeckles fuse to 
larger speckles (Shav-Tal et al., 2005). However, the Fall pattern does not change after 
actinomycin D treatment (data not shown). In addition, immunostaining experiments 
confirmed that Fall did not show any overlap with SC-35, a nuclear speckle marker (data 
not shown). These results are consistent with no significant splicing defect detected in 
fall mutants.  
Interestingly, the appearance of the Fall speckles is also similar to insulator bodies, 
another type of liquid-liquid phase separation which has been proposed to regulate 3D 
genome organization (Gómez-Díaz and Corces, 2014). Upon osmotic stress, insulator 
bodies fuse together and form large bodies localized to the nucleus periphery (Schoborg 
et al., 2013). Indeed, Fall showed a similar pattern when NaCl or sucrose induced 
osmotic stress was applied. However, we only found partially association of Fall with 
CP190, a marker of insulator bodies in Drosophila, upon osmotic stress. Thus, Fall may 
form a novel class of insulator proteins or represents a new group of proteins capable of 
forming liquid-liquid phase separation that influences transcription. Noteworthy, we 
observed that bona fide insulator body proteins do also not overlap entirely. In 
developing IFM, CP190 and BEAF-32 bodies do not completely overlap while CP190 
and Mod(mdg4)67.2 showed an identical localization pattern. 
2.2.3.3 Structural function analysis of Fall 
Fall protein consists of a N-terminal BTB domain and two C-terminal zinc finger motifs. 
We have investigated their function separately by replacing the endogenous gene with 
Fall protein variants, including Fall-2HA, Fall-ΔBTB-2HA, and Fall-ΔZFs-2HA, at the 
endogenous locus. Their expression has been confirmed by HA staining. In fall-2HA 
flies, Fall protein showed a identical localization pattern with Fall-GFP and the IFM 
developed normally and the flies fly. Interestingly, flies lacking either BTB or ZFs 
displayed a similar phenotype to the fall null allele; they are homozygous viable, 
flightless, and show the same muscle atrophy as the fall null. By immunostaining, we 
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have confirmed that deletion of either of the two domains results in hypercontracted 
muscle fibers with significantly shortened sarcomeres, suggesting that both domains are 
required for normal sarcomere maturation during IFM development. BTB deletion leads 
to a nuclear localization defect of Fall which is prominent at 48h APF. In contrast to wild 
type or Fall-ΔZF-HA, the Fall-ΔBTB-2HA protein is almost exclusively located to the 
cytoplasm rather than nuclei. At 72h APF, slight enrichment of Fall-ΔBTB-2HA in 
nuclei has been seen. Detailed characterization revealed that the Fall-ΔBTB-2HA failed 
to form liquid-liquid phase separation after osmotic stress treatment, while Fall-ΔZF-HA 
behaves similarly to Fall protein. These results strongly suggest that both BTB and ZFs 
are important for correct Fall function in IFMs. However, it is unclear if the nuclear body 
formation is coupled to the physiological function of Fall, since it is unknown which part 
of fall is essential for entering nuclear bodies but dispensable for normal localization to 
nuclei. 
2.2.4 BTB-zinc finger proteins and conservation 
2.2.4.1 BTB-ZFs are conserved across organisms 
BTB-ZF (Broad-complex, Tramtrack and Bric-a-brac Zinc Finger) proteins are a large 
group of transcriptional regulators characterized by a N-terminal localized BTB domain 
and a series of C-terminally localized zinc finger motifs. They have been found in 
Drosophila proteins Broad-complex, Tramtrack, and Bric-a-brac initially and named 
after them (Siggs and Beutler, 2012). Hundreds of proteins belonging to this family have 
been found from virus, insects to humans. Roles for BTB-ZF proteins in several 
developmental and pathological processes including neuronal patterning, axon branching, 
leukemic translocation, and tumorigenesis are established (Siggs and Beutler, 2012). The 
N-terminally localized BTB domain is frequently involved in dimerization or 
multimerization, while the zinc finger domains often bind to DNA and determine 
sequence specificity. Apart from promoting dimerization, BTB domain also recruits other 
transcription regulators such as NcoR (nuclear receptor corepressor) and SMRT 
(silencing mediator for retinoid and thyroid hormone receptor) or chromatin remodellers 
CTCF and BEAF-32 to modify the chromatin status (Dhordain et al., 1997; Gómez-Díaz 
and Corces, 2014; Huynh and Bardwell, 1998), and thereby repress or activate the 
expression of their targets. Noteworthy, in Drosophila, a group of BTB-ZF proteins, 
including CP190, Su(Hw), and Mdg(mdg4)67.2, interact with each other and are capable 
of forming the insulator bodies in order to partition chromatin domains, and thus regulate 
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transcription (Gómez-Díaz and Corces, 2014). However, despite of a few established 
roles of BTB-ZF proteins, the functions and downstream targets of many BTB-ZF 
proteins are unknown.  
2.2.4.2 Nuclear body formation: a common feature of BTB-ZF 
proteins? 
In Drosophila, several BTB-ZFs proteins, including Su(Hw), Mod(mdg4)67.2, CP190, 
and Fall potentially localize to different liquid-liquid phase separation compartments. 
Surprisingly, in vertebrates, a few well-characterized proteins such as PLZF and Bcl-6 
have also been found to be able to form nuclear bodies, which are also enriched for their 
binding partners SMRT and NcoR (Dhordain et al., 1997; Huynh and Bardwell, 1998; 
Koken et al., 1997; Reid et al., 1995). Notably, they exert their function by deacetylating 
histones, and thereby regulate chromatin states (Downes et al., 2000). These results 
indicate that nuclear body formation may represent a general character of BTB-ZFs, and 
nuclear bodies provide a restricted compartment for particular BTB-ZFs to function by 
specific chromatin modification. 
During the past decades, several nuclear bodies have been identified and characterized 
(Mao et al., 2011). However, their biophysical properties have been explored only 
recently (Zhu and Brangwynne, 2015). Biophysical investigations have suggested that 
the nuclear bodies or non-membrane bound compartments are organized by long non-
coding RNAs or protein polymers and are liquid-liquid phase separations (Hyman et al., 
2014; Mitrea and Kriwacki, 2016). The composition and function of nuclear bodies is 
still intriguing. Proteins enriched for tandem repeats of individual amino acids or 
repetitive amino acid motifs such as polyasparagine (PolyN) and polyglutamine (PolyQ) 
are often found to locate to liquid-liquid phase separations (Bergeron-Sandoval et al., 
2016; Kato et al., 2012). Disruption of these elements abolished their capacity to 
organize or enter the liquid-liquid separations (Altmeyer et al., 2015). Other molecular 
elements determining the ability of proteins to enter and exit the nuclear bodies are still 
elusive. The newly identified Fall protein may serve as a useful model for elucidating the 
general physiological function of the speckle formation or deformation behavior. 
Furthermore, Fall is only expressed and functions in body muscles, providing a nice tool 
to study BTB-ZFs proteins properties and functions in a tissue-specific context. 
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2.2.4.3 Fall: a homolog of ZBTB42 in fly? 
Although BTB-ZF proteins have been found in many organisms, it is hard to determine 
their evolution path since they normally consist of a long low-complexity region that is 
very flexible despite of the conserved BTB domain. Interestingly, ZBTB42, a BTB zinc 
finger protein in vertebrates, has been shown to be expressed in skeletal muscles 
(Devaney et al., 2011). Point mutation in ZBTB42 leads to lethal congenital contracture 
syndrome, which is characterized by multiple contractures displayed at distal joints. 
Moreover, knockdown of ZBTB42 in zebrafish result in abnormal skeletal muscle 
development and sarcomere disorders (Patel et al., 2014). Although the underlying 
mechanism is still elusive, it may employ a similar regulatory path with fall. Together, 
these data suggest that BTB zinc finger proteins (ZBTB42 and fall) represent a new group 
of regulators of skeletal muscle development. Upon mutation, misregulated downstream 
targets could induce skeletal muscle hypercontraction. Thus, the mechanistic 
investigation of Fall may largely extend our understanding of human pathology caused 
by mutations in ZBTB42. 
2.3 Outlook 
Some questions remain to fully understand the role of Fall during IFM development. 
First, how Fall does regulate its targets? It may bind to DNA directly and act as a classic 
transcription factor or work together with chromatin remodelers such as CTCF to 
modulate chromatin state or architecture. Furthermore, it is unclear that if the localization 
of Fall to nuclear bodies is coupled to its physiological function. To answer these 
questions, it would be interesting to perform IP-mass spectrometry to identify its binding 
partners using Fall-GFP and Fall-2HA as bait. Additionally, mapping the upstream 
regulatory sequences of Fall targets may provide information about how Fall regulates its 
targets. Since ChIP-seq technology is still challenging to apply to specific tissue, the 
novel DNA adenine methyltransferase identification (DamID) method would be a 
potential alternative (Aughey and Southall, 2016). 
Second, what are the upstream regulators that determine the spatial-temporal expression 
of fall and restrict its function specifically to sarcomere maturation stage? fall starts to be 
expressed after myofibrillogenesis initiation (30h APF) and functions largely during 
sarcomere maturation. 
Discussion and Outlook 
 
 38 
Third, although Fall is expressed in many body muscles during development, the 
phenotype was only observed in IFM. How its function is restricted to IFMs is still 
unknown. One possibility is a IFM-specific interaction partner which is missing in jump 
muscle and leg muscles may exist. Another possibility is that the targets regulated by Fall 
are specifically important for sarcomere growth and maturation in IFMs. More detailed 
analysis of direct targets and interaction partners may help to answer this question. 
Finally, it would be also interesting to identify its orthologue in vertebrate if it exists. 
And thus, the results that we obtained from Drosophila may also provide information for 
understanding sarcomerogenesis in vertebrate. ZBTB42 might be a good candidate. 
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a b s t r a c t
Drosophila is a well-established genetic model organism: thousands of point mutations, deficiencies or
transposon insertions are available from stock centres. However, to date, it is still difficult to modify a
specific gene locus in a defined manner. A potential solution is the application of transcription
activator-like effector nucleases (TALENs), which have been used successfully to mutate genes in various
model organisms. TALENs are constructed by fusion of TALE proteins to the endonuclease FokI, resulting
in artificial, sequence-specific endonucleases. They induce double strand breaks, which are either
repaired by error-prone non-homologous end joining (NHEJ) or homology directed repair (HDR). We
developed a simple TALEN-based protocol to mutate any gene of interest in Drosophila within
approximately 2 months. We inject mRNA coding for two TALEN pairs targeting the same gene into
embryos, employ T7 endonuclease I screening of pooled F1 flies to identify mutations and generate a
stable mutant stock in the F3 generation. We illustrate the efficacy of our strategy by mutating
CG11617, a previously uncharacterized putative transcription factor with an unknown function in Dro-
sophila. This demonstrates that TALENs are a reliable and efficient strategy to mutate any gene of interest
in Drosophila.
! 2014 Elsevier Inc. All rights reserved.
1. Introduction
Drosophila melanogaster is a classical model to investigate gene
function in a complex, multi-cellular organism. Starting with the
legendary Heidelberg screen for embryonic patterning [1,2] and
followed by hundreds of its derivatives, forward genetic screens
have been immensely powerful to discover genes and study their
functions in Drosophila biology (reviewed in [3]). Forward screens
per definition hit the genome at random and thus discover new
roles for genes in a particular biological context.
Reverse genetics, on the other hand, tests gene function by a
targeted approach manipulating one particular gene of interest.
After 30 years of forward screens, reverse genetics is currently
booming in Drosophila, as many large scale systematic approaches
such as interaction proteomics [4] or genome-wide RNAi screens
[5–7] suggest a function for a given gene without providing classi-
cal loss of function mutations. Tools to apply reverse genetics in
Drosophila have advanced rapidly in the last years, in particular
through gene targeting by homologous recombination that allows
gene modification at the endogenous gene locus, similar to the ap-
proach in mice [8,9]. However, despite significant progress in the
gene targeting protocol enabling smart genetic selection methods
[10], it remains relatively tedious to engineer a particular gene of
interest to either a genetic null allele or a tagged protein allele.
The recent implementation of zinc-finger nucleases in Drosophila
opened a promising new path for gene engineering [11,12],
but zinc-finger design is laborious and has certain sequence
restrictions. Mixed-success reports, most likely dependent on the
target sequence [13], have prevented the technology from taking
off as a routine application for generating mutants in the average
fly lab.
Transcription activator-like effector nucleases (TALENs) are de-
rived from naturally occurring transcription factors present in
plant pathogens called TALEs, which contain 12–27 repeats,
typically composed of 34 amino acids. Each repeat binds to a single
base pair of DNA, with the two central variable amino acids
determining base specificity [14,15]. In TALENs, the C-terminal
transcriptional activation domain has been replaced by the FokI
nuclease domain, converting a transcriptional activator to a se-
quence specific nuclease. As FokI cleaves only as a dimer, TALENs
are used in pairs that bind on opposite DNA strands, separated
by a central spacer domain. TALEN-induced double strand DNA
breaks are either repaired by non-homologous end joining (NHEJ),
http://dx.doi.org/10.1016/j.ymeth.2014.03.020
1046-2023/! 2014 Elsevier Inc. All rights reserved.
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which often results in small insertions or deletions and is thus
valuable to mutate genes, or by homology directed repair (HDR)
using the homologous chromosome or a provided homologous
DNA sequence, which can be used for gene engineering [16]. This
strategy has been applied to a number of different organisms or
cell types, including Arabidopsis, zebrafish, and human cell lines,
to mutate genes or insert DNA sequences into a locus of interest
[17–20]. In addition to their straight forward application, TALENs
are more flexible than zinc-fingers as they can recognise any
DNA sequence and also appear to have higher target specificity
and lower toxicity [19,21,22].
In Drosophila, TALENs have mainly been used to mutate genes
that result in visible phenotypes such as changes in eye or body
colour. Thus, they can easily be scored in the F1 generation [22–
24]. Lately, this technology has been expanded to also mutate
genes with unknown phenotypes in Drosophila [22] or to insert
GFP into desired locations in the fly genome [24], demonstrating
the potential of TALEN-mediated genome editing. Here, we report
Fig. 1. Overview of TALEN application to generate Drosophilamutants. Blue boxes highlight the 6 distinct steps in the procedure to generate a null allele for a given Drosophila
gene by the application of TALENs. These steps include the design of TALEN pair target sequences within the first coding exon (1); assembly of each TALEN pair using the
Golden Gate cloning kit (2); in vitro transcription, polyadenylation and capping of TALEN mRNAs (3); co-injection of mRNAs for two TALEN pairs into fly embryos (4);
identification of F1 carriers by T7 endonuclease I screening (5); and generation of stable mutant F3 stocks (6). The red box estimates the required time for each step.
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a simple and effective protocol to apply TALEN-mediated genome
engineering in order to mutate any gene of choice in Drosophila.
Our protocol can easily be performed by a standard Drosophila lab-
oratory without the need to purchase special equipment. We gen-
erate mosaic G0 adult flies by injecting Drosophila embryos with
mRNAs coding for two pairs of TALENs that target next to each
other in the same gene region. We apply a T7 endonuclease I
screening assay to detect heterozygous mutant carriers amongst
the F1 generation and generate a mutant stock using the F3 gener-
ation. Together, this allows the effective generation of mutations in
any Drosophila gene within about 2 months.
2. Materials and methods
2.1. Cloning of TALEN pairs
Addgene TALEN kit (Addgene).
pCS2TAL3-DD/RR backbone plasmid (Addgene).
QIAprep Spin Miniprep Kit (Qiagen).
QIAGEN Plasmid Midi Kit (Qiagen).
Bsa I and BsmB I (NEB).
T4 ligase (NEB).
Plasmidsafe nuclease (Epicentre).
Tetracycline 10 lg/ml (Sigma–Aldrich).
Spectinomycin 50 lg/ml (Sigma–Aldrich).
Ampicillin 100 lg/ml (Sigma–Aldrich).
2.2. Plasmid linearisation and in vitro transcription of TALEN pairs
Not I (NEB).
10% SDS (Sigma–Aldrich).
Protease K (Sigma–Aldrich).
Phenol/Chloroform/Isopropanol (v:v:v = 25:24:1).
3 M NaOAc (pH 5.2).
RNase free Eppendorf tubes (1.5 ml) and tips.
mMESSAGE mMACHINE! T7 ULTRA Kit (Ambion).
mMESSAGE mMACHINE! SP6 Kit (Ambion).
2.3. Embryo injections
Klorix (bleach) to dechorionate the embryos.
Scotch tape dissolved in heptane to glue the dechorionated
embryos on a slide for injection.
Silica gel orange (Roth) to dry dechorionated embryos before
injection.
10 S Voltalef oil (Lehmann and Voss) to cover the dechorionated
embryos during injections.
Glass capillaries (Harvard Apparatus) and needle puller (Sutter
Instruments) to pull injection needles.
Eppendorf FemtoJet for injections.
2.4. T7 endonuclease I screening
Fly genomic DNA extraction buffer A (0.1 M Tris, pH 9.0; 0.1 M
EDTA; 1% SDS; 5 M KOAc, pH 4.8).
Taq polymerase (NEB).
T7 endonuclease I (NEB).
96-well plates.
3. Application of TALENs to Drosophila
Fig. 1 illustrates the different steps in our protocol, starting with
design of the TALEN target sequences and ending with the final
mutant Drosophila stock. The entire protocol can be completed in
about 2 months.
3.1. Design of two TALEN pairs to modify a gene
Identify a region of about 0.2–1 kb in your target gene which
you intend to modify, and confirm its sequence in the fly strain
that will be used for the engineering experiment (here white1118).
To generate a genetic null allele of a given gene, the first coding
exon is often a convenient target (Fig. 1-1). Use the TAL Effector
Nucleotide Targeter 2.0 (https://tale-nt.cac.cornell.edu) program
to design suitable TALEN pairs for the target region by using
the following recommended parameters: minimum spacer
length = 15, maximum spacer length = 16, minimum repeat array
length = 18, maximum repeat array length = 20, upstream
base = T only, off-target sequence = D. melanogaster genome
[25]. Rank the outcome for the lowest off-target predictions
and choose two pairs of TALENs that do not overlap and thus
can create independent mutations at two different positions in
the target gene.
3.2. Assembly of TALEN pairs
Assemble four TALENs (two pairs) for each gene region that
should be mutated using the Golden Gate kit and its assembly pro-
tocol in a standard 20 ll reaction. All required plasmids are avail-
able from Addgene [17] and the detailed protocol can be
downloaded from http://www.addgene.org/static/cms/files/Gold-
enGateTALAssembly2011.pdf. In the first assembly step, repeat-
variable di-residues (RVDs) 1–10 and 11–20 are assembled
(Fig. 1-2). In the second assembly step, both assembled units are
combined with the last repeat. In the final step, clone the assem-
bled TALENs into pCS2-TAL3-DD and RR, a convenient vector with
an SP6 RNA polymerase promoter and a SV-40 termination site for
efficient in vitro transcription [19].
3.3. In vitro transcription, capping and poly-adenylation of TALEN
pairs
Linearise the TALEN vectors obtained in step 3.2 by standard
methods using Not I digestion under RNase free conditions. Using
the mMESSAGE mMASCHINE T7 Ultra and SP6 kits, assemble a
10 ll in vitro transcription reaction in the following order at room
temperature:
Reagent Volume per
reaction (ll)
Final concentration
2 ! NTP/ARCA
(T7 Ultra kit)
5 7.5 mM ATP; 7.5 mM CTP;
7.5 mM UTP; 1.5 mM GTP;
6 mM ARCA
Linearised
template
3 "600ng
10 ! reaction
buffer (SP6 kit)
1 1!
SP6 enzyme mix 1
This combination of both Ambion kits enables SP6-driven tran-
scription combined with ARCA capping. Incubate at 37 "C over
night.
Add 0.5 ll TURBO DNase (2 U/ll) and incubate at 37 "C for
20 min. Assemble the polyadenylation reaction using the mMES-
SAGE mMASCHINE T7 Ultra kit in the following order:
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Reagent Volume per
reaction (ll)
Final
concentration
Transcription product 10 !10–15 lg
Nuclease-free water 18
5 " E-PAP buffer 10 1"
25 mM MnCl2 5 2.5 mM
10 mM ATP solution 5 1 mM
E-PAP 2 0.08 U ll#1
Incubate at 37 !C for 45 min, then stop the reaction and precip-
itate the RNA with 30 ll LiCl (7.5 M). Incubate for 30 min at #20 !C,
centrifuge, wash with 70% EtOH, dry and re-suspend the RNA in
10 ll RNase free water. This should produce 10–15 lg ARCA
capped polyA mRNA that can be analysed for integrity on a gel
and is ready for embryo injections.
3.4. Embryo injection of TALEN pairs
For each target gene locus, inject capped mRNA of two TALEN
pairs mixed in water at concentrations of 250 ng/ll for each TALEN
mRNA leading to a total concentration of 1 lg/ll. Such high TALEN
mRNA concentrations result in higher G0 lethality, ultimately
reducing the following fly work. Inject !400 white1118 embryos at
the posterior pole before germ-cell formation using standard injec-
tion procedures. This usually results in about 30–60 viable and fer-
tile G0 mosaic adults (Fig. 2-1).
3.5. Identification of F1 carriers by T7 endonuclease I assay
Collect mosaic G0 males and virgins and cross them singly to
balancer flies. This normally is in the range of 30–60 G0 crosses
per gene. As the G0 flies are mosaic, their F1 offspring may or
may not carry the desired mutation. It is most efficient to pool F1
flies to identify which carry an inheritable mutation. For each G0
cross, set up 5 vials with 8 F1 males per vial and cross them with
more than 10 balancer virgins (F2 cross, Fig. 2-2). After 4 days, re-
cover the 8 mated F1 males from each pool, fill each pool into single
wells of a 96 well plate and homogenise all flies carefully. Extract
genomic DNA as published previously [26].
The presence of a mutation in the desired gene within
each F1 pool is determined by T7 endonuclease I assay. Set up a
standard 20 ll PCR from each isolated DNA pool amplifying
0.5–1 kb of the gene region including both TALEN target regions
(Fig. 1-5):
Reagent Volume per
reaction (ll)
Final
concentration
10 " PCR buffer 2 1"
50 mM MgCl2 0.2 2 mM (total Mg2+)
10 mM dNTPs 0.5 250 lM
10 lM primer mix 0.4 200 nM each primer
Polymerase 0.15 0.0375 U ll#1
DNA template 1 !300 ng
H2O to final volume
of 20 ll
15.75
Perform the PCR and final denaturation and annealing steps
using the following program:
Step Temperature (!C) Time
Initial denaturation 95 5 min
Denaturation 95 30 s
Annealing 64 45 s
Extension 68 60 s
Repeat 30 cycles
Final extension 68 5 min
Final denaturation 95 5 min
Final annealing step 1 95–85 #2 !C/s
Final annealing step 2 85–25 #0.1 !C/s
Hold 4 Indefinitely
PCR products that are a mixture of a mutated allele (base pair
insertions or deletions) and a wild-type allele result in a DNA
mismatch at the TALEN target site and will be cleaved by T7
endonuclease I using the following reaction mix that is assembled
on ice:
Reagent Volume per
reaction (ll)
Final
concentration
10 " T7 buffer 2 1"
5 U/ll T7 endonuclease I 0.5 0.125 U ll#1
Annealed PCR product 10 !600 ng
H2O to final volume of 20 ll 7.5
Incubate the digestion 15–20 min at 37 !C and analyse the
products on a 1.5% agarose gel immediately to avoid over-digestion
(Figs. 1-5 and 2-2).
Reagent Volume per
reaction (ll)
Final
concentration
10 " T7 buffer 2 1"
5 U/ll T7 endonuclease I 0.5 0.125 U ll#1
Annealed PCR product 10 !600 ng
H2O to final volume of 20 ll 7.5
3.6. Recovery of mutant alleles and generation of stable mutant stock
From each F1 vial that is positive in the T7 endonuclease I assay,
cross 20 single F2 males to balancer virgins and test the F3 offspring
with the same T7 endonuclease I assay. Upon obtaining a positive
T7 result, a mutant stock can be generated from the remaining F3
males and virgins (Fig. 2-3). Finally, sequence the target gene
region of the heterozygous stock to determine the nature of the
new mutation.
4. Results and discussion
We applied our protocol to generate null alleles of the putative
Zn-finger transcription factor CG11617 (Fig. 3-1). CG11617 is lo-
cated at 21B4 on the second chromosome and mutant alleles have
not been described. Following the above protocol, we designed two
TALEN pairs targeting the first coding exon of CG11617 (Fig. 3-2).
We injected a mixture of all four TALEN mRNAs into 400 white1118
embryos, resulting in 36 fertile G0 flies that we crossed with If/CyO
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males or virgins. Using the T7 endonuclease I assay, we identified
five F1 candidate mutant carriers originating from five different
G0 crosses and were able to recover all five mutant candidates as
F3 stocks (Fig. 3-1). DNA sequencing revealed that CG116171 con-
tains a 14 bp deletion in the spacer region of the first TALEN pair,
located in the first coding exon of CG11617. This results in a frame
shift and thus is predicted to be a genetic null allele (Fig. 3-3). The
other four independent CG11617 alleles all contain exactly the
same 11 bp deletion in the spacer region of the second TALEN pair,
which is also located within the first coding exon of CG11617.
These are also predicted to be genetic null alleles. It may initially
appear surprising to generate the identical mutation several times;
however, similar observations have been made by the application
of TALENs in rat embryos [27] or CRISPR in mouse embryos [28].
These results show the value of injecting two TALEN pairs at the
same time: even if one TALEN pair is not effective in generating a
mutation (a fact that has been observed in systematic studies using
TALENs to mutate genes in human cell lines [29]), mutations
caused by the second TALEN pair can additionally be isolated from
the same batch of injected embryos. This reduces the fly work and
in particular the time consuming PCR and T7 endonuclease screen-
ing assays. Using this strategy, we have been able to generate
several null alleles for three novel genes. In some cases, the se-
quence between both TALEN pairs is entirely deleted (X.Z., F.S.
unpublished results). Thus, our protocol is very time effective as
injection of only 400 embryos reliably results in mutations in the
gene of interest. In the future, this approach should allow to effi-
ciently generate mutations in any Drosophila gene of interest and
with slight modifications of the injection and screening procedure,
would also enable insertion of short tags into a target gene to
efficiently tag a protein of choice.
A similar protocol can also be applied to modify Drosophila
genes using the recently develop CRISPR-Cas9 system. Effective
generation of mutations in Drosophila using a transgenic source
for Cas9 as well as for the gRNAs has been recently reported
[30]. While being very effective in mutating the target gene, this
method requires the generation of transgenic stocks for each of
the gRNAs used to target a gene and thus is potentially more time
consuming. In addition, CRISPR-Cas9 carries a much higher off-tar-
get rate when compared with TALENs [31], which is potentially
even higher, when the fly expresses active Cas9 and gRNA in the
germ line for several generations. Furthermore, the use of CRISPR
has some sequence restrictions [32] compared to TALENs making
TALENs a more flexible reagent.
Fig. 2. Detailed overview of fly work and mutant stock establishment. Blue boxes highlight the 3 major steps in the fly work to generate a new TALEN-mediated mutant stock.
After assembly, mRNAs for TALEN pairs are injected into embryos and mosaic G0 flies are singly crossed to a balancer line (1). 40 F1 males are isolated from each G0 cross,
pooled into groups of 8 and crossed to a balancer line. Males are recovered and screened by the T7 endonuclease I assay to keep only F2 vials with mutant carriers (2). 20
males are selected from positive F2 vials, singly crossed to a balancer line and rescreened with T7 endonuclease I to isolate F3 vials carrying the mutation and generate a stable
mutant stock (3). An orange colour denotes wild-type, while red denotes mutants.
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1. Workflow for generation of null alleles for CG11617:
400 white1118 
  embryos
36 mosaic G0 36 F1 vials 5 F1 carriers 5 F3 mutant stocks
CG116171 - 14 bp deletion (1st TALEN pair): 
CG116172, 3, 4, 5 - 11 bp deletion (2nd TALEN pair): 
...CCAGCATCCCGAGCTACAAAGAGATTATTTACTCCCGACATTAAGAGGATGCTAA...TTACTTACACTCAGATTTGCAATTGGTTTGCAAACTGGCGAAGAAAGCTTAAA...
CG11617-RB
CG11617-RA
left TALEN 1 target left TALEN 2 targetright TALEN 1 target right TALEN 2 targetspacer spacer
...CCAGCATCCCGAGCTACAAAGA--------------GACATTAAGAGGATGCTAA...TTACTTACACTCAGATTTGCAATTGGTTTGCAAACTGGCGAAGAAAGCTTAAA...
...CCAGCATCCCGAGCTACAAAGAGATTATTTACTCCCGACATTAAGAGGATGCTAA...TTACTTACACTCAGATTTGCAA-----------ACTGGCGAAGAAAGCTTAAA...
3. Molecular nature of 5 independently isolated CG11617 alleles: 
2. TALEN target sequences in CG11617 genomic locus:
Fig. 3. Generation of null alleles for CG11617 via TALENs. The workflow to obtain CG11617 null alleles is illustrated in (1). TALEN target sequences in the CG11617 locus are
illustrated in (2). The molecular nature of the 5 independently isolated CG11617 mutants is diagrammed in (3). Grey bars represent non-coding sequences and orange bars
coding sequences. Green bases denote target sequences. Red bases denote spacer sequence between TALEN recognition sites. Dashes represent missing sequence in mutant
alleles.
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ABSTRACT The development of clustered, regularly interspaced, short palindromic repeats (CRISPR)/
CRISPR-associated (Cas) technologies promises a quantum leap in genome engineering of model organisms.
However, CRISPR-mediated gene targeting reports in Drosophila melanogaster are still restricted to a few
genes, use variable experimental conditions, and vary in efﬁciency, questioning the universal applicability of
the method. Here, we developed an efﬁcient two-step strategy to ﬂexibly engineer the ﬂy genome by
combining CRISPR with recombinase-mediated cassette exchange (RMCE). In the ﬁrst step, two sgRNAs,
whose activity had been tested in cell culture, were co-injected together with a donor plasmid into transgenic
Act5C-Cas9, Ligase4 mutant embryos and the homologous integration events were identiﬁed by eye ﬂuores-
cence. In the second step, the eye marker was replaced with DNA sequences of choice using RMCE enabling
ﬂexible gene modiﬁcation. We applied this strategy to engineer four different locations in the genome, in-
cluding a gene on the fourth chromosome, at comparably high efﬁciencies. Our data suggest that any ﬂy
laboratory can engineer their favorite gene for a broad range of applications within approximately 3 months.
KEYWORDS
Drosophila
CRISPR/Cas9
homologous
recombination
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Reverse genetics is currently booming with the establishment of TALEN-
and CRISPR-mediated genome engineering (Hsu et al. 2014; Sander and
Joung 2014; Joung and Sander 2013). In particular, the CRISPR/Cas9
technology appears to efﬁciently and speciﬁcally introduce double strand
DNA breaks in the genome of the organism, which can then be utilized
to either introduce point mutations by error-prone nonhomologous
end-joining (NHEJ) or integrate heterologous DNA into the chromo-
some using the homology-directed repair (HDR) pathway (Sander and
Joung 2014). In Drosophila, CRISPR-induced NHEJ has mainly been
utilized to mutate genes that result in a visible, easily scored phenotype,
such as white eyes or yellow body color, or to mutate GFP transgenes
(Gratz et al. 2013a; Sebo et al. 2014; Ren et al. 2013; Bassett et al. 2013).
Mutants in genes with no visible phenotype required PCR screening for
their identiﬁcation; therefore, high mutagenesis rates are important,
which might be difﬁcult to achieve at all positions in the ﬂy genome
(Kondo and Ueda 2013; Yu et al. 2013, 2014; Gokcezade et al. 2014; Port
et al. 2014). Recently, this bottleneck was addressed by applying
CRISPR-induced HDR to insert an attP-site together with a visible
marker into the gene of interest (Baena-Lopez et al. 2013; Gratz et al.
2014; Xue et al. 2014). In some cases the visible marker was ﬂanked by
FRT or loxP sites allowing its excision to only leave one attP site (and
one loxP or FRT site) within the gene. This attP site enables the
introduction of any given DNA sequence into the gene of interest
(Baena-Lopez et al. 2013; Gratz et al. 2014; Xue et al. 2014). However,
the efﬁciency of reporter integration was rather low (Baena-Lopez et al.
2013) and only determined at a single genomic locus (Gratz et al. 2014;
Xue et al. 2014), leaving the general applicability to the Drosophila
genome an open question. Port et al. (2014) reported an alternative
CRISPR-mediated HDR strategy by using a transgenic single guide
RNA (sgRNA) source and crossing it to a transgenic Cas9 source. This
method also enabled targeting of somatic cells in a tissue-speciﬁc man-
ner, but it required the generation of new transgenic sgRNA lines for
every locus (Port et al. 2014).
Here, we have developed a highly ﬂexible two-step genome engi-
neering platform that combines CRISPR-mediated HDR with FC31
recombinase-mediated cassette exchange (RMCE). In the ﬁrst step,
CRISPR is applied to integrate a splice acceptor and an SV40 terminator
Copyright © 2014 Zhang et al.
doi: 10.1534/g3.114.013979
Manuscript received August 19, 2014; accepted for publication October 11, 2014;
published Early Online October 15, 2014.
This is an open-access article distributed under the terms of the Creative
Commons Attribution Unported License (http://creativecommons.org/licenses/
by/3.0/), which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
Supporting information is available online at http://www.g3journal.org/lookup/
suppl/doi:10.1534/g3.114.013979/-/DC1
1Corresponding author: Max Planck Institute of Biochemistry, Am Klopferspitz 18,
D-82152 Martinsried, Germany. E-mail: schnorrer@biochem.mpg.de
Volume 4 | December 2014 | 2409
together with a 3xP3-dsRed eye reporter. This enables both the efﬁcient
identiﬁcation of the targeted event and the creation of a strong loss of
function allele. In the second step, two ﬂanking attP sites are utilized to
replace the inserted DNA by any DNA of choice using RMCE, an
established standard technology in Drosophila (Venken et al. 2011).
Together, this allows ﬂexible cassette exchange to freely manipulate
the gene of interest. We successfully applied this method to four differ-
ent locations in the genome and efﬁciently generated several allele
variants, including a conditional allele, from a single targeting event.
Our streamlined CRISPR/Cas9-based and RMCE-based strategies make
it practical to ﬂexibly engineer anyDrosophila gene of choice for a broad
range of applications within approximately 3 months.
MATERIALS AND METHODS
Fly strains and genetics
All ﬂy work, unless otherwise stated, was performed at 25! under
standard conditions. The Lig4[169] null allele (McVey et al. 2004)
was obtained from the Bloomington Drosophila Stock Center, and
y[1], M(Act5c-Cas9, [w+]) in M(3xP3-RFP.attP)ZH-2A, w[1118] was
a gift from Fillip Port and Simon Bullock before publication (Port et al.
2014). Both markers (w+ and 3xP3-RFP) were removed by crossing to
heat-shock-Cre. The y[1], M(Act5C-Cas9)ZH-2A, w[1118] ﬂies were
recombined with Lig4[169] to obtain y[1], M(Act5C-Cas9)ZH-2A,
w[1118], Lig4[169].
Cell culture
Drosophila Schneider 2 (S2) cells stably expressing myc-Cas9 from a
ubiquitin promoter were a gift from Klaus Förstemann before publi-
cation (Böttcher et al. 2014). S2 cells were cultured in Schneider’s
Drosophilamedium supplemented with 10% fetal calf serum (Life Tech-
nologies) and penicillin/streptomycin (GE Healthcare). sgRNA activities
were tested by transfecting 1 mg sgRNA per 24 wells into the myc-Cas9
cells using Fugene HD (Promega), followed by DNA extraction and
a T7-Endonuclease I assay (see supplied protocol for details).
Plasmids
CC6-U6-gRNA_hsp70-Cas9 plasmid was a gift from Peter Duchek
before publication (Gokcezade et al. 2014). pJET1.2-STOP-dsRed:
attP1 and splicing acceptor (SA) were ampliﬁed with primers XZ82
and XZ83, SV40 terminator with XZ84 and XZ85, and attP2 with
XZ88 and XZ89 from DNA extracted from a MiMIC ﬂy line (Venken
et al. 2011); 3xP3-dsRed was ampliﬁed from a fosmid ﬂy line (Langer
et al. 2010) with primers XZ86 and XZ87. These fragments were cloned
into pLR-HD plasmid by Golden Gate cloning (Cermak et al. 2011).
This assembled attP1-SA-STOP-SV40-3xP3-dsRed-attP2 cassette was
ampliﬁed with primers XZ195 and XZ196 and blunt cloned into
pJET1.2 to generate pJET1.2-STOP-dsRed. Because this STOP-dsRed
cassette is ﬂanked by two BsmBI sites, it can be easily assembled with
both homology arms (Figure 3A): each homology arm of approximately
1 kb was ampliﬁed from genomic DNA of the target genotype with
Phusion polymerase (NEB) and blunt-end cloned into pJET1.2
(CloneJET PCR Cloning Kit, Thermo Scientiﬁc). Primers used to am-
plify the homology arms have a 59 BsmBI site enabling Golden Gate
assembly with the STOP-dsRed cassette. All primers used are listed in
Supporting Information, Table S1. pBS-donor-backbones pBS-GGAC-
TTCT, pBS-GGAC-ATGC, and pBS-CGGA-GTGC were constructed
by linearizing pBluescript with KpnI and SacII, followed by ampliﬁcation
with primer pairs XZ150 and XZ151, XZ156 and XZ151, and XZ161
and XZ162, respectively, and re-ligation. The generated pBS-donor-
backbones harbor two BsmBI sites for donor plasmid assembly.
pJET1.2-STOP-dsRed, pJET1.2-HA-left, pJET1.2-HA-right, and an ap-
propriate pBS-backbone were assembled to the pBS-donor vector by
Golden Gate cloning. attB plasmids FRT-2xTY1-FRT-V5 and 2xTY1-
V5 fragments were synthesized as gBlocks (IDT) and cloned into the
attB plasmid for all three reading frames. For construction of CC6-U6-
gRNA_hsp70-Cas9-sgRNA1,3,4,7 and 9 the CC6-U6-gRNA_hsp70-
Cas9 vector was cut with BbsI (NEB) and the annealed sgRNA targeting
oligos were cloned into it. The vas-FC31(3xP3-EGFP.attB) plasmid was
obtained from Johannes Bischof (Bischof et al. 2007). The attB site was
removed by digestion with SpeI, followed by re-ligation.
All plasmids for embryo injections were puriﬁed with PureLink
HiPure Plasmid Midiprep Kit (Life Technologies). Oligos are listed in
Table S1.
sgRNA synthesis
The sgRNA dsDNA template was produced using overlap PCR with
a small amount of a common sgRNA scaffold primer, a shorter sgRNA
ampliﬁcation primer, and a sgRNA gene-speciﬁc primer that includes
the T7 promoter (Figure 3C) (Böttcher et al. 2014). All sgRNA primer
sequences are listed in Table S1. The PCR product was cleaned by
Qiagen MinElute kit (Qiagen). The sgRNAs were transcribed with
T7-MEGAshortscript Kit (Life Technologies) and puriﬁed with
MEGAclear Transcription Clean-Up Kit (Life Technologies).
Embryo injection
Preblastoderm embryos of the appropriate genotype were de-chorionated
and injected with a FemtoJet apparatus (Eppendorf) using self-pulled
glass needles (Harvard Apparatus) under standard conditions at room
temperature. Injected embryos were kept for 2 d at 18! and the hatched
larvae were collected and grown at 25!. For step 1 injections, pBS-donor
plasmid, two sgRNAs, and (optionally) the CC6-U6-gRNA_hsp70-Cas9
plasmid were mixed and diluted in water. Lig4[169] embryos were
injected with CC6-U6-gRNA_hsp70-Cas9 plasmid (100 ng/ml) and
pBS-donor plasmid (500 ng/ml). y[1], M(Act5C-Cas9)ZH-2A, w[1118],
Lig4[169] embryos were injected with both sgRNAs (60–70 ng/ml each)
and pBS-donor plasmid (500 ng/ml). For step 2 injections, the attB
plasmid (150 ng/ml) was mixed with vasa-FC31 plasmid (200 ng/ml).
Immunolabeling of IFMs: Hemi-thoraces of adult Drosophila were
prepared and stained as described (Weitkunat and Schnorrer 2014).
Rabbit anti-Salm was used at 1:50 (Kühnlein et al. 1994), mouse anti-
Flag (Sigma), mouse anti-V5 (Abcam), and rhodamine phalloidin
(Invitrogen) were all used at 1:500. Nuclei were visualized by embed-
ding in Vectashield plus DAPI (Vector Laboratories) and images were
acquired on a Zeiss LSM780 confocal and processed with FIJI and
Photoshop.
Detailed Drosophila genome engineering protocol
by CRISPR-RMCE
1. CRISPR-sgRNA design and donor plasmid cloning !10 d
1.1 Verify sequence of the planned targeting regions for the
sgRNAs in the ﬂy strain used and in the S2 cells by sequencing
to identify potential polymorphisms compared with the pub-
lished sequence.
1.2 For designing the sgRNA targeting sites, choose one of the
web tools (Beumer and Carroll 2014). We used an interface
designed by the Zhang laboratory (http://crispr.mit.edu).
1.3 sgRNA production
1.3.1 Generate the dsDNA template for sgRNA in vitro tran-
scription as described by Böttcher et al. (2014).
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1.3.2 Transcribe sgRNA by T7-MEGAshortscript Kit (AM1354;
Life Technologies). Use 150- to 250-ng template for a 20-ml
reaction at 37! overnight.
1.3.3 Purify sgRNA by MEGAclear Transcription Clean-Up Kit
(Life Technologies). Follow the manufacturer’s protocol and,
in step 3, add an equal volume of 100% ethanol to the sample.
1.3.4 Check the sgRNA integrity on a gel and measure the con-
centration using a photometer (Nanodrop, Thermo Scien-
tiﬁc). The expected yield is 50–100 mg, which is enough for
the S2 cell assay and the ﬂy injections.
1.4 sgRNA activity assay in S2 cells
1.4.1 Grow S2 cells in Schneider medium with 10% FCS (Life
Technologies) to 5–10 · 106 cells/ml at 25!.
1.4.2 Dilute cells to 0.7 · 106/ml and plate 1 ml cells in S2
medium with 10% FCS per well in a 24-well plate for each
transfection.
1.4.3 Prepare the transfection mix by diluting 1 mg sgRNA in 50
ml serum free medium and 4 ml Fugene HD mix plus 46 ml
serum free medium, mix both, and incubate for 45 min at
room temperature.
1.4.4 Add the Fugene/RNA mix to each well and mix gently by
pipetting.
1.4.5 After 48–60 hr at 25!, harvest the cells and extract the
genomic DNA by QIAamp DNA mini kit (Qiagen).
1.4.6 For the T7 Endonuclease I assay, amplify an approximately
500-bp fragment, which harbors the sgRNA targeting site
with Phusion polymerase (NEB), and denature and anneal
the PCR product as described by Zhang et al. (2014).
1.4.7 Mix on ice 10 ml annealed PCR product with 10 ml T7
Endonuclease I master mix [2 ml T7 endonuclease I buffer,
0.5 ml T7 endonuclease I (5 units, NEB) and 7.5 ml water].
1.4.8 Digest at 37! for 15–20 min using a PCR machine and load
on 1.5% agarose gel immediately.
1.4.9 Estimate the efﬁciency of different sgRNAs by comparing
the band intensities of the digested and nondigested bands.
1.5 Generation of donor plasmid (can be performed in parallel
with steps 1.3 and 1.4 to save time)
1.5.1 Amplify left and right homology arms (approximately 1 kb,
start as close to the sgRNA cutting site as possible) with Phusion
polymerase (NEB) from the ﬂy strain that is used for HDR and
clone them into pJET-1.2 according to the CloneJET PCR Clon-
ing Kit (Thermo Scientiﬁc).
1.5.2 Assemble the Golden Gate Cloning reaction [50 ng pBS-
backbone, 80 ng pJET1.2-HA-left, 80 ng pJET1.2-HA-right,
80 ng pJET1.2-STOP-dsRed, 1.5 ml 10x T4 ligation buffer, 1 ml
BsmBI (NEB, R0580), 1 ml T4 ligase (NEB, M0202) add water
to 15 ml].
1.5.3 Ligate in PCR machine using the following cycles: 15 cycles
of 37!, 5 min/16!, 10 min/37!, 15 min/50!, 5 min/80!, and
5 min/4!.
1.5.4 Assemble the Plasmid-safe nuclease reaction (15 ml ligation
reaction 3 ml 10· Plasmid-safe buffer 1.2 ml 25 mM ATP 1 ml
Plasmid-safe nuclease (Epicentre) 9.8 ml water).
1.5.5 Incubate at 37! for 60 min in PCR machine and transform
5–10 ml in bacteria. Most growing colonies will be correct.
2. Fly step 1 - CRISPR-mediated HDR !6 wk
2.1 Inject 600–800 Act5C-Cas9, lig4[169] embryos with pBS-
donor (500 ng / ml) and two sgRNAs (each 60–70 ng/ml, target-
ing close to the chosen homology arms). Collect at least 50
fertile mosaic G0 ﬂies.
2.2 Cross G0 ﬂies individually (at least 50 vials) either to yw ﬂies
or appropriate balancer ﬂies and screen all the F1 progeny for
ﬂuorescent red eyes using a ﬂuorescent binocular (Leica
MZ16-FA). Keep track of how many independent G0 founders
lead to how many F1 carrier ﬂies.
2.3 Generate stocks from an individual F1 carrier by crossing to
balancer ﬂies resulting in an isogenized stock for the engineered
chromosome. Verify the targeting event by PCR and sequencing.
3. Fly step 2: FC31-mediated RMCE !6 wk
3.1 Inject a “generic” plasmid generated by Venken et al. (2011) or
this study or your own custom-made gene-speciﬁc attB plasmid
(150 ng/ml) mixed with vasa-FC31 plasmid (200 ng/ml) into ap-
proximately 200 embryos from an ampliﬁed stock generated at 2.3.
3.2 Cross G0 ﬂies individually to an appropriate balancer and
screen all F1 progeny for nonﬂuorescent eyes using a ﬂuores-
cent binocular (Leica MZ16-FA).
3.3 Generate stocks from an individual F1 carrier by crossing to
balancer ﬂies, resulting in an isogenized stock for the engi-
neered chromosome. Verify the correct orientation of the
RMCE by PCR (will be !50%).
RESULTS
Strategy overview
We aimed to develop a versatile and efﬁcient strategy to modify the
Drosophila genome that would allow various genome modiﬁcations
such as the introduction of single point mutations, protein tags, exon
deletions, or other desired changes in the gene of choice. Despite the
suggested higher efﬁciency of CRISPR/Cas9-induced HDR as com-
pared with Zn-ﬁnger–induced or TALEN-induced HDR, the identiﬁ-
cation of successfully targeted carrier ﬂies is still a limiting step in the
process. PCR-based screening or melting curve analysis methods require
DNA extraction (Beumer et al. 2013a), which can be inconvenient for
efﬁcient stock generation. Therefore, we decided to develop a two-step
strategy as illustrated in Figure 1, which enables efﬁcient identiﬁcation of
the carrier ﬂies and allows entirely ﬂexible genome engineering. In the
ﬁrst step, we insert a 3xP3-dsRed marker enabling easy identiﬁcation of
the HDR event. A strong splice acceptor, followed by STOP codons and
an SV40 polyA terminator, precedes the dsRed cassette. The inserted
DNA is ﬂanked by two attP sites in opposite orientations, a strategy that
we adapted from the popular MiMIC system (Venken et al. 2011). If this
cassette is inserted into an intron or replaces an endogenous exon, then
it results in truncated mRNA of the targeted gene. Thus, step 1 can be
used to create a loss-of-function allele (Figure 1).
In the second step, RMCE is applied to replace the DNA between
both attP sites by any DNA of choice, leaving a minimal scar of two attR
sites, preferably in introns. RMCE has been used very efﬁciently in the
MiMIC system, demonstrating that attR sites in introns generally do not
interfere with gene function (Venken et al. 2011). Hence, our strategy
enables the generation of various alleles, like a deﬁned point mutation,
a tagged allele, an exon replaced by a tag, or a conditional allele, from
a single HDR carrier (Figure 1). This strategy should allow ﬂexible edit-
ing of any Drosophila gene within approximately 3 months (Figure 2).
CRISPR design and cloning
In step 1, we aimed to insert a STOP-3xP3-dsRed cassette ﬂanked by
two attP sites using a donor plasmid (Figure 1). Because the same
strategy should be applicable to any gene, we established a single-step
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Golden Gate protocol to assemble the STOP-dsRed donor plasmid
containing approximately 1-kb homology arms on each side, which
has been shown to be of sufﬁcient length for efﬁcient HDR (Beumer
et al. 2013b) and can be easily ampliﬁed by PCR. Cloning of the ho-
mology arms into the donor vector is thus very straightforward and
takes only a few days for the gene of choice (Figure 3A, see Materials
and Methods). This donor vector is the template for the HDR in step 1.
In step 2, RMCE exchanges the STOP-dsRed by any sequence
located between two attB-sites in a provided donor plasmid (Figure 1).
RMCE works very reliably and a large collection of plasmids to tag
genes or insert reporters for various applications is available (Venken
et al. 2011). These plasmids are fully compatible with our step 2 de-
sign. We have generated additional “generic” attB plasmids that can be
used to tag any gene with a 2xTY1-V5 tag or to engineer a conditional
allele using an FRT ﬂanked 2xTY1 cassette followed by a V5 tag
(Figure 3B). Flp-mediated deletion of the 2xTY1 cassette will lead to
a frame shift and thus can be used to create loss-of-function clones at
very high efﬁciency, as the ﬂip-out will occur in cis (Hadjieconomou
et al. 2011). The TY1 tag is a convenient afﬁnity tag (Sarov et al.
2012). We have generated both constructs in all three reading frames.
Figure 1 A two-step method to ﬂexi-
bly engineer the ﬂy genome. Overview
of the two-step procedure. In step 1, a
donor vector consisting of two attP sites
(P), a splice acceptor (SA), and STOP
codons (yellow box, black asterisk) fol-
lowed by an SV40 polyadenylation signal
(pA) and a 3xP3dsRed marker are in-
serted on Cas9 cleavage with two
sgRNAs. The orange coding exon is
excised. In step 2, FC31-mediated
RMCE inserts any DNA sequence be-
tween the two attB sites (B). Examples
for various engineered exons are given,
resulting in attR sites (R) in introns. F
stands for FRT.
Figure 2 Two-step genome engineering timeline.
Schematic overview of the major steps of the genome
engineering procedure. Details are provided inMaterials
and Methods.
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CRISPR activity assay in cell culture
Many search algorithms exist to predict sgRNA target sequences for
a given gene region (Beumer and Carroll 2014). However, to date there
is no simple way of conﬁrming if any of the predicted sgRNAs work
efﬁciently. We developed such a selection assay to be able to only inject
effective sgRNAs into ﬂy embryos. We designed 12 different sgRNAs
targeting different regions in the salm gene and synthesized the sgRNAs
by a standard PCR and in vitro transcription reaction (Figure 3C). These
sgRNAs were then individually transfected into Cas9 expressing S2 cells
(Böttcher et al. 2014), and their cleavage efﬁciency was determined with
a simple T7-Endonuclease I assay (see Materials and Methods) (Zhang
et al. 2014). On average, approximately half of the tested sgRNAs work
efﬁciently in this assay (Figure 3D), strongly suggesting that such a pre-
selection test is useful to improve the in vivo success rates.
Step 1: HDR in Lig4 mutant embryos
To test the efﬁciency of inserting our STOP-dsRed cassette, we
designed three donor constructs targeting different regions in the salm
gene (Figure 4A): the ﬁrst, deleting parts of exon 1; the second, insert-
ing the cassette into intron 1; and the third, deleting exon 3. For each
construct approximately 1-kb homology arms were cloned in the
STOP-dsRed donor vector. We injected the STOP-dsRed donor as
circular plasmid together with two plasmids each containing a U6
promoter-driven sgRNA veriﬁed in S2 cells and a hsp70-Cas9 source
(seeMaterials and Methods). We injected into Ligase4mutant embryos,
which were reported to exhibit a higher rate of HDR than wild-type
embryos (Beumer et al. 2013a,b). We injected between 700 and 1500
embryos for each of the three constructs and were able to recover 11
red-eyed F1 carriers from two independent founders for the ﬁrst intron
construct and 72 red-eyed F1s from four independent founders for the
third exon deletion construct (Table 1). This demonstrated that our
strategy works in principle, but because we failed to recover the ﬁrst
exon deletion allele, we wanted to further improve the efﬁciency by
using a different Cas9 source.
Step 1: Transgenic Cas9 improves HDR efﬁciency
A number of transgenic Cas9 ﬂies have been generated recently, and
some of which have been used successfully (Ren et al. 2013; Xue et al.
2014; Gratz et al. 2014; Port et al. 2014). To test whether a transgenic
Cas9 source is more efﬁcient for HDR than a source from an injected
plasmid, we targeted the same positions as above, but now using
Act5C-Cas9, Lig4 ﬂies. For this, we recombined an Act5C-Cas9 transgene
Figure 3 Cloning scheme and sgRNA
activity tests. (A) Single-step Golden
Gate assembly scheme of the STOP-
dsRed donor vector cloned into a mod-
iﬁed pBluescript backbone. (B) Scheme
of the “generic” attB plasmids used in
our study. A simple cloning step is suf-
ﬁcient to generate any gene-speciﬁc
attB plasmid that can be used to re-
place an excised exon. (C) sgRNA syn-
thesis scheme. (D) sgRNA activity assay
of 12 different sgRNAs in S2 cells. PCR
result with (bottom) or without (middle)
T7-Endonuclease I treatment are shown.
Digested products are marked by arrow
heads and effective sgRNAs are marked
by a red asterisk. C are controls without
sgRNA.
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expressing Cas9 ubiquitously, including maternally in the germline (Port
et al. 2014), with the Lig4[169] null allele. Additionally, we removed the
white and 3xP3dsRed markers from the Act5C-Cas9 transgene to obtain
a Act5C-Cas9, Lig4[169] chromosome that is useful for the injection of
our donor plasmids (see Materials and Methods). We injected 700
Act5C-Cas9, Lig4[169] embryos with two in vitro transcribed sgRNAs
targeting either the ﬁrst exon, the ﬁrst intron, or the third exon of salm
(using the same sgRNA target sequences as used above). We obtained
one, nine, and four independent founders producing 13, 54, and 59 F1
carriers, respectively, demonstrating that all three locations were tar-
geted successfully with frequencies between 3% and 14% per fertile G0
(Table 1). To verify that the targeted insertion occurred correctly, we
tested a total of nine independent carriers from the three locations by
PCR and sequencing. We were able to conﬁrm that all of these tar-
geted correctly by “ends-out” homologous recombination. We did not
detect any “ends-in” insertions, which were reported to occur occa-
sionally (Yu et al. 2014) (Figure S1 shows salm[1st intron-dsRed] as an
example).
The ﬁrst step of our gene-targeting strategy inserts a strong splice
acceptor followed by a STOP cassette into the gene and thus should
terminate transcription at this position. By design, the salm[1st exon-
dsRed] allele additionally has a deleted ATG. As expected, the salm[1st
exon-dsRed] allele is homozygous lethal, as well as lethal in trans to
salm[1], demonstrating that we created a strong salm loss-of-function
allele (Figure 5A). The salm[1st intron-dsRed] allele harbors an inser-
tion in the ﬁrst intron (Figure 4A). This allele is also homozygous
lethal, and lethal in trans to salm[1], suggesting that the splice acceptor
and STOP cassette are used efﬁciently to create a strong loss-of-
function allele (Figure 5A). The salm[3rd exon-dsRed] allele only dele-
tes the last 36 amino acids of the long SalmPA isoform, including
10 amino acids of the last zinc ﬁnger (Figure 4A). This allele is ho-
mozygous viable (Figure 5A). Taken together, these data suggest that
our CRISPR-mediated step 1 strategy works efﬁciently to isolate tar-
geted carrier ﬂies at a practical frequency for routine use. Conveniently,
these step 1 alleles are generally loss-of-function alleles if the insertion
is located within the gene.
Figure 4 Engineering of the salm gene.
(A) Step 1 engineering of the salm gene.
The genomic salm organization is de-
picted with coding exons in orange.
The sgRNA targeting sites are indicated
by red arrows and the resulting salm[1st
exon-dsRed], [1st intron-dsRed] and [3rd
exon-dsRed] alleles are shown. (B) Step
2 engineering of the salm gene. RMCE
products of the salm[1st intron-dsRed]
with three different exon cassettes are
shown.
n Table 1 Summary of the transformation efﬁciencies for the four different genomic locations modiﬁed in this study
Location
Injected
Genotype sgRNAs
Injected
Embryos Larvae
G0
Adults
Fertile
G0
Adults
Independent
G0
Founders
Total
Red-Eyed
F1
Independent
Founders Per
Fertile G0s
salm[1st exon-dsRed] Lig42/2 sgRNA1 + sgRNA3 1500 396 166 ND 0 0 ND
salm[1st intron-dsRed] Lig42/2 sgRNA3 700 171 149 ND 2 11 ND
salm[3rd exon-dsRed] Lig42/2 sgRNA7 + sgRNA9 1500 312 150 ND 4 72 ND
salm[1st exon-dsRed] Act5C-Cas9, Lig42/2 sgRNA1 + sgRNA3 700 124 48 30 1 13 3.3%
salm[1st intron-dsRed] Act5C-Cas9, Lig42/2 sgRNA3 + sgRNA4 700 200 122 64 9 54 14.1%
salm[3rd exon-dsRed] Act5C-Cas9, Lig42/2 sgRNA7 + sgRNA9 700 291 150 99 4 59 4.0%
bent Act5C-Cas9, Lig42/2 bent -sg1 + bent -sg3 700 204 118 56 1 5 1.8%
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Step 2: Flexible gene editing by RMCE
A major beneﬁt of our editing strategy is the ﬂexible step 2 that enables
the near-seamless insertion of any DNA sequence with only two
remaining attR sites (Figure 1). To test the feasibility of step 2, we chose
the salm[1st intron-dsRed] allele. We exchanged the STOP-dsRed cassette
with a short 2xTY1-V5 exon, a FRT-2xTY1-FRT-V5 conditional exon,
and a large GFP-3xFLAG exon from Venken et al. (2011) (Figure 4B).
As expected, in all three cases the cassette exchange worked routinely
and, typically, injection of approximately 200 embryos is sufﬁcient to
obtain two or more RMCE events in the correct orientation (see
Materials and Methods). Importantly, the salm[1st intron-dsRed] le-
thality was reverted by RMCE in all three cases (Figure 5B). This
demonstrates that our editing protocol generally does not result in
any unwanted lethal mutations on the edited chromosome.
Salm protein is expressed in indirect ﬂight muscles (IFMs) and is
essential for ﬁbrillar IFM fate speciﬁcation (Schönbauer et al. 2011).
Thus, we should detect the tagged Salm protein versions in the IFM
nuclei of adult ﬂies. Tagged protein from all three alleles, salm[1st intron-
TY1-V5], salm[1st intron-FRT-TY1-FRT-V5], and salm[1st intron-GFP-
FLAG] is expressed in IFMs. Salm-TY1-V5 and Salm-GFP-FLAG are
readily detected in the IFM nuclei, and Salm-FRT-TY1-FRT-V5 shows
an additional dotty pattern in the cytosol, which might be caused by the
FRT sequence translated into protein (Figure 5C–G). The ﬁbrillar IFM
morphology is normal in all three homozygous salm alleles, showing
that the tagged Salm proteins are indeed functional. Each IFM ﬁber
contains several hundred nuclei. The conditional salm[1st intron-FRT-
TY1-FRT-V5] should now enable a clonal loss-of-function analysis of
salm in muscle only, as ﬂip-out in cis is highly efﬁcient (Hadjieconomou
et al. 2011). Thus, this strategy should generally be versatile for the
genetic analysis of muscle in the future.
Gene editing on the fourth chromosome
To demonstrate the general applicability of our gene editing strategy,
we decided to apply it to an additional locus. We chose the bent gene,
located on chromosome four, which is highly heterochromatic and
thus difﬁcult to manipulate by standard genetic tools. To our knowledge,
there is only a single case reported in the literature that targeted a gene
located on the fourth chromosome by classical ends-out mediated
Figure 5 Phenotypic analysis of the engineered salm alleles. (A) Lethality assay of the salm-dsRed alleles as homozygous or in trans to salm[1]. (B)
All tagged salm[1st intron] alleles regain homozygous viability after step 2. (C–G) Localization of the tagged Salm proteins. Untagged Salm is
located in the nucleus of wild-type IFMs (C, E), whereas V5 tagged Salm is only detected in the salm[1st intron-TY1-V5] and the salm[1st intron-FRT-
TY1-FRT-V5] alleles (D, G). FLAG is found in the IFM nuclei of salm[1st intron-GFP-FLAG] adults (F). The Salm-FRT-TY1-FRT-V5 protein is found in
the nuclei (red arrow heads) and also located in dots in the cytoplasm (G). Note the normal ﬁbrillar morphology of the myoﬁbrils in all the
homozygous salm[1st intron] alleles (D, F, G). Actin was stained with phalloidin and the scale bars are 10 mm.
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homologous recombination using long homology arms (Rodriguez-
Jato et al. 2011). bent is a very large gene composed of at least 46 exons
that are spread across more than 51 kb of genomic DNA (Figure 6).
bent encodes for Projectin, a titin-like protein that is speciﬁcally
expressed in muscles and essential for correct sarcomeric organization
(Fyrberg et al. 1992; Ayme-Southgate et al. 1995; Schnorrer et al. 2010).
It is supposedly silent in germ cells, in which the targeting event must
happen. We chose to delete exon 11, an exon at the beginning of the
PEVK domain of Projectin (Ayme-Southgate and Southgate 2006), using
two sgRNAs ﬂanking the exon. Both sgRNAs tested positively in the S2
cell assay (data not shown). We again used approximately 1 kb homol-
ogy arms and injected the donor vector into 700 Act5C-Cas9, Lig4[169]
embryos. We isolated ﬁve carriers from 1 founder out of a total of
56 fertile G0 ﬂies, resulting in an HDR efﬁciency of 1.8%. We conﬁrmed
the bt[11th intron-dsRed] allele by sequencing of the locus. As expected,
bt[11th intron-dsRed] is homozygous lethal and also lethal in trans to
bt[I-b], a strong bent allele (Ayme-Southgate et al. 1995), again suggest-
ing that the inserted splice acceptor is used effectively and transcription
is prematurely terminated. Together, these results demonstrate that our
CRISPR-mediated targeting strategy also works efﬁciently on the fourth
chromosome, suggesting it can be generally applied to any locus of
choice in the ﬂy genome.
DISCUSSION
CRISPR/Cas9 has been used successfully in many model organisms to
generate mutants or to introduce targeted changes by HDR (Hsu et al.
2014). In Drosophila, there has been no general agreement regarding
which strategy works most effectively to engineer the genome. To simply
mutate a gene by CRISPR/Cas9-induced NHEJ, Cas9 was either injected
as mRNA (Bassett et al. 2013; Yu et al. 2013), provided from an injected
plasmid (Gratz et al. 2013a; Baena-Lopez et al. 2013), or provided from
a transgenic source (Kondo and Ueda 2013; Ren et al. 2013; Sebo et al.
2014). Similarly, the sgRNA was either injected as in vitro transcribed
sgRNA or provided by an injected plasmid or a transgenic source. A
standard protocol has not yet emerged, although several genes have been
mutated.
NHEJ can only induce small insertions or deletions. In contrast,
HDR allows the deﬁned engineering of a given gene and thus is suitable
for a much wider range of applications. CRISPR/Cas9-mediated HDR
has been used in Drosophila to insert short attP or tag sequences from
single-strand oligonucleotides as donors (Gratz et al. 2013a) or larger
cassettes including a dsRed marker cassette from a plasmid donor
(Baena-Lopez et al. 2013; Yu et al. 2014; Gratz et al. 2014; Xue et al.
2014), again using various ways of injected or transgenic sources of
sgRNAs or Cas9. The injected genotype was variable; sometimes Lig4
mutants were used (Baena-Lopez et al. 2013; Yu et al. 2014; Gratz et al.
2014; Xue et al. 2014), sometimes they were not used (Baena-Lopez
et al. 2013; Yu et al. 2014; Gratz et al. 2014; Xue et al. 2014; Gokcezade
et al. 2014; Port et al. 2014). Often the detection of the targeted event
required laborious ﬂy screening by PCR (Gratz et al. 2013b; Yu et al.
2014; Gokcezade et al. 2014).
Here we aimed to develop a universal and efﬁcient CRISPR-based
strategy that enables ﬂexible genome engineering, including the insertion
of large tags into the coding region of a gene or the generation of
conditional alleles. This strategy should be generally applicable to most
Drosophila genes. Our results conﬁrmed that approximately 1-kb ho-
mology arms are of sufﬁcient length to insert a large marker cassette, as
has been suggested before for other loci (Gratz et al. 2014; Yu et al. 2014;
Xue et al. 2014; Port et al. 2014). Thus, we could develop an efﬁcient
donor plasmid assembly protocol that facilitates cloning of the donor
vector for any gene within a few days. Additionally, our data support the
value of a quick pretesting strategy of predicted sgRNAs in S2 cells to
eliminate inefﬁcient sgRNAs, which would likely reduce targeting efﬁ-
ciency in vivo. However, we have not tested how well sgRNA efﬁciencies
in S2 cells correlate with efﬁciencies in vivo. Conveniently, the same
in vitro transcribed RNAs can be used for both S2 cell transfections
and embryo injections. Our results suggest that a transgenic Cas9 source
mediates HDR effectively in Ligase4 mutant germline cells. Although
Act5C-Cas9 expression is not restricted to the germline, injections of the
donor vector together with two veriﬁed sgRNAs led to a targeting efﬁ-
ciency of 2%–14% of fertile G0 ﬂies for the incorporation of the large
STOP-dsRed cassette, even for the bent locus on the heterochromatic
fourth chromosome. This suggests that approximately 50–100 fertile G0
ﬂies should be sufﬁcient in most cases to identify positive carriers. We
and others (Gokcezade et al. 2014) have observed relatively high de-
velopmental lethality of the injected G0 ﬂies, which might be caused by
somatic knock-out of the targeted gene. Thus, survival rate of the
injected embryos and larvae might be increased when using a germ-
line-restricted Cas9 source, such as nos-Cas9. However, nos-Cas9 was
reported to be less efﬁcient in germline transmission compared with
Act5C-Cas9 (Port et al. 2014). We thus far have deleted up to approx-
imately 1 kb of genomic sequence by HDR. Larger deletions would likely
occur at reduced efﬁciencies; however, the dsRed marker should still
make it practical to ﬁnd them. The straightforward identiﬁcation of
carriers together with our simple cloning scheme should easily facilitate
the insertion of the STOP-dsRed cassette into the gene of choice.
Recent reports using a transgenic sgRNA source (Port et al. 2014)
or an injected sgRNA source (Ren et al. 2014) report very effective
Figure 6 Engineering of the bent
gene. The entire genomic bent
organization is shown at the top
with a 10-kb zoom-in below. Cod-
ing exons are in orange. The
sgRNA targeting sites ﬂanking
exon 11 are indicated by red
arrows and the resulting bent
[11th exon-dsRed] allele is shown
at the bottom.
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HDR rates with more than 50% of the fertile G0 ﬂies being positive
founders and, thus, screening by PCR-based methods were practical in
these cases. However, both studies used only a single locus to insert
the GFP tagging cassette; hence, a direct comparison with the efﬁcien-
cies that we report here is difﬁcult.
Our two-step strategy combines the advantages of both CRISPR
and RMCE, thus allowing very ﬂexible modiﬁcations of a particular
gene region with minimal effort. Multiple ﬂuorescent and afﬁnity tags
can be easily inserted or a deleted exon can effectively be replaced by
various engineered exon versions. In principle, larger gene parts con-
sisting of multiple exons can also be deleted and replaced by modiﬁed
versions. This method is particularly valuable for genes that harbor
complex transcriptional control and function in many tissues such as
salm or for genes that are exceptionally large and exhibit complex
alternative splicing patterns such as bent. The two-step strategy allows
structure–function analysis at the endogenous locus without interfering
with the regulatory regions included in introns, which cannot be
achieved by simply inserting a cDNA at the transcriptional start site.
The functionality of our method was veriﬁed by the reversion of the
lethality for the step 2 alleles in the ﬁrst intron of salm. This furthermore
suggests that both steps do not generate additional unintended changes
on the chromosome. Therefore, we hope that our strategy will promote
the wide application of CRISPR-mediated HDR in Drosophila, making
it a routine tool used in every ﬂy laboratory like EMS mutagenesis or
P-element–mediated transformation was in the past century.
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Abstract 
Skeletal muscles utilize sarcomeres to produce active contractile forces that enables 
animal movements. Sarcomeres are complex stereotype units with a pseudo-crystalline 
regularity of actin, myosin and titin filaments. How these regular units are built during 
development is poorly understood. Here, we study the Drosophila flight muscles in order 
to better understand how the initially 1.7 µm long immature sarcomeres mature to the 3.2 
µm long sarcomeres of the adult. We identified the novel BTB-zinc finger fallen angel 
(fall, CG32121) as a muscle-specific transcriptional regulator in a genome-wide RNAi 
screen in Drosophila. Fall is specifically expressed during sarcomere maturation in flight 
muscles and forms nuclear bodies, which localize close to but are distinct from insulator 
bodies. Interestingly, fall mutants show a defect in sarcomere maturation resulting in too 
short sarcomeres, which produce too high forces. This results in rupturing of the muscle-
tendon apparatus during development and a severe muscle atrophy in adult fall mutant 
animals. Mechanistically, we show that Fall regulates the induction of a subset of 
sarcomeric genes, which are specifically induced during sarcomere maturation. Thus, 
Fall ensures the correct stoichiometry of sarcomeric components, allowing their pseudo-
crystalline assembly in mature contractile sarcomeres. BTB-zinc finger proteins 
constitute are large conserved protein family and we speculate that a similar defect might 
be the cause of the fatal congenital contractures found in humans with mutation in 
ZBTB42, underscoring the general important of correct sarcomere maturation in higher 
animals. 
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Introduction 
Muscles produce forces to power the controlled movements of all higher animals. The 
force producing mini-machines of muscle fibers are the sarcomeres. Sarcomeres are 
stereotyped units of pseudo-crystalline regularity: both ends of bipolar myosin (thick) 
filaments located in the sarcomere center are facing towards polar actin (thin) filaments, 
which are cross-linked at defined Z-discs bordering each sarcomere. The two filaments 
systems are stably connected by flexible titin filaments (Ehler and Gautel, 2008). Both, 
the molecular components as well as the architectural organization of sarcomeres are 
conserved from invertebrates to humans (Vigoreaux, 2006), enabling a myosin sliding 
mechanism to produce force during sarcomere contraction in all species (Huxley and 
NIEDERGERKE, 1954; Huxley and Hanson, 1954). 
Different muscle fiber types can differ in their exact sarcomeric composition (Schiaffino 
and Reggiani, 2011; Spletter and Schnorrer, 2014), however sarcomere length is 
precisely controlled for each fiber type, ranging from 3.0 to 3.4 µm in relaxed human 
muscle in vivo (Llewellyn et al., 2008). Hence, both sarcomeric architecture as well as 
sarcomeric force production must be regulated accurately to build a functional sarcomere 
during muscle development. 
Muscle development is a multi-step process. Myoblasts fuse to form myotubes (Kim et 
al., 2015), myotubes elongate to attach both ends to tendon cells (Schnorrer and Dickson, 
2004; Schweitzer et al., 2010), and finally myotubes convert to myofibers by assembling 
their myofibrils. Myofibril formation is also a complex and multi-step process that is not 
well understand in molecular detail (Sanger et al., 2010; Sparrow and Schöck, 2009). It 
was recently shown that mechanical tension is important to coordinate the simultaneous 
assembly of early immature myofibrils that span across the muscle fiber (Lemke and 
Schnorrer, 2016; Weitkunat et al., 2014). These immature myofibrils undergo a complex 
maturation process resulting in the pseudo-crystalline structure of mature myofibrils and 
sarcomeres (Sanger et al., 2010; Spletter et al., 2015). Defects in sarcomere maturation 
can cause muscle hyper-contraction resulting in severe muscle atrophy already during 
development or within the first days of life in flies (Montana and Littleton, 2004; Spletter 
et al., 2015) as well as in vertebrates (Johnston et al., 2000; Patel et al., 2014; Robinson 
et al., 2007). Thus, correct sarcomere and myofibril maturation are critical for correct 
force production and thus for muscle function. 
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We use the Drosophila indirect flight muscles (IFMs) to study the mechanism of 
myofibril and sarcomere maturation. Early immature myofibrils display a muscle myosin 
II pattern with a periodicity of about 1.8 µm at 30 h APF and about 1.9 µm at 48 h APF 
(pupae raised at 27 ºC) (Weitkunat et al., 2014). Until eclosion (> 90 h APF at 27 ºC) the 
myofibrils mature to a thickness of about 1.4 µm, and each sarcomere elongates to its 
final length of 3.2 µm displaying its pseudo-crystalline regularity (Reedy and Beall, 
1993; Spletter et al., 2015; Weitkunat et al., 2014). Correct sarcomere morphology and 
function require the correct stoichiometry of all sarcomeric components. This is most 
impressively shown by the dominant flightless phenotypes of heterozygous mutations in 
muscle myosin heavy chain (Mhc) {Bernstein:1983vq} or flight muscle specific actin 
(Act88F) (Cripps et al., 1994). Similarly, a mutation in the regulatory region of troponin I 
(wupA), resulting in reduced levels of the troponin complex, cause flightlessness and 
flight muscle atrophy in adults (Firdaus et al., 2015). Analogously, mutations in a large 
number of sarcomeric proteins cause dominant cardiomyopathies in humans 
{Seidman:2001dn}. Hence, correct stoichiometry of the numerous sarcomeric 
components must be tightly controlled during myofibril formation and maturation. 
We have found that the expression of a significant set of sarcomeric components is 
strongly induced in flight muscles from 48 h APF onwards, thus ensuring correct 
sarcomere maturation (Spletter, Zhang & Schnorrer, manuscript in preparation). 
However, apart from the general muscle specific transcriptional regulator Mef2, which 
continuously required during IFM development (Soler et al., 2012), and the IFM specific 
transcriptional regulator Spalt major (Salm), which is important for expression of most 
IFM specific genes and gene isoforms (Schönbauer et al., 2011; Spletter et al., 2015), we 
know little about the transcriptional regulation of muscle during sarcomere maturation. 
Here, we identify an important role for fallen angel (fall, CG32121), a member of the 
conserved BTB-zinc finger family of transcriptional regulators, to boost transcription of 
a subset of sarcomeric proteins whereas down-regulating others. Upon mutation of fall, 
an incorrect stoichiometry of sarcomeric proteins in mutant flight muscles leads to 
uncontrolled force production, muscle hypercontraction and muscle atrophy during 
stages of normal sarcomere maturation. Thus, fall adjusts the muscle-specific 
transcriptional program to the enable correct sarcomere maturation. 
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Methods and materials 
Fly strains and genetics 
All fly work was performed at 27 °C under standard conditions unless specified. 
CG32121 deficiency line (w1118; Df(3L)ED4502, P{3'.RS5+3.3'}ED4502/TM6C, cu1 Sb1) 
was obtained from Bloomington stock center. Fall-GFP Fosmid (FF10059) was 
generated as described (Sarov et al., 2016). Fall-GFP Fosmid (FF10059) was recombined 
with fall[1] or fall[2] respectively and the recombinant was identified by PCR for the 
rescue experiment. The tissue specific rescue was performed at 18 degree by driven UAS-
fall-HA (obtained from Johannes Bischof (Bischof et al., 2013)) with a IFM specific 
driver Actin88F-GAL4 (Bryantsev et al., 2012) in the fall[1] or fall[2] background. 
Hypercontraction rescue were performed with Mhc[10]; fall[1] or Mhc[10]; fall[2] flies 
by using the IFM specific myosin mutant Mhc[10](Collier et al., 1990). In order to 
reinforce the resistance of muscle tendon attachment, a constitutively-active form of 
Rap1 was overexpressed in IFM by driven UAS-Rap1-GFP-CA or UAS-Rap1-HA-CA 
(Ellis et al., 2013)(from Guy Tanentzapf) with Actin88f-GAL4 (Bryantsev et al., 2012) in 
fall[1] background. This cross was done at 18 degree to eliminate the adverse effect 
caused by the Actin88f-GAL4 itself. Flies bearing an extra copy of Pinch-FL (Pronovost 
et al., 2013)(from Julie L. Kadrmas) were balanced with fall[1] to generate Pinch-FL; 
fall[1]. Tendon cell labeling was performed by crossing UAS-CD8GFP with stripe-
GAL4 as control and crossing UAS-CD8GFP; fall[1] with fall[1], stripe-GAL4, 
recombinant of fall[1] and a tendon cell specific driver stripe-GAL4 (Fernandes et al., 
1996). The indirect flight muscles were labeled with Mef2-GAL4; UAS-gmaGFP to 
facilitate the dissection of samples for RNA-seq and proteomics. Both CTCF[GE24185] 
and CTCF[P30.6] (from Rainer Renkawitz) (Mohan et al., 2007) are strong alleles for 
CTCF. BEAF-32[AB-KO] {Roy:2007gq} (from Robert J Johnston Jr) is a null allele for 
both BEAF-32A and BEAF-32B. CP190[1] and CP190[2] (Butcher, 2004)were obtained 
from Jordan Raff. 
Generation of fall[1] and fall[2] alleles 
fall[1] was generated as described in published TALEN methods (Zhang et al., 2014a). 
Briefly, two pairs of TALENs (pair 1 targeting AACCGCAGCATCATC in the first 
coding exon of fall and pair 2 targeting ACTCCGGAGAGGTGA in the second coding 
exon of fall) have been designed and constructed respectively. In vitro transcribed 
TALEN mRNAs were injected into w1118 fly embryos at a concentration of 250 ng/µl 
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each. The genomic region covering both targeted sites have been amplified by PCR with 
primer XZ13 and XZ14 and then followed by T7 assay to identified successful targeting. 
Fly stocks with expected mutation have been established and characterised by 
sequencing afterwards. 
fall[2] was constructed by CRPSPR-based genome editing as published with small 
optimisation (Zhang et al., 2014b). In brief, the intron sequence between coding exon 1 
and 2 of fall and sequence from the end of 3’UTR of fall was chosen for sgRNA 
designing with CRISPRscan (Moreno-Mateos et al., 2015). Four sgRNAs were picked 
for targeting each region according to the score from CRISPRscan and their activities 
were estimated in S2 cells as described (Zhang et al., 2014b). sgRNA 1 (targeting 
sequences GTGTAATGCGGTGAAAGCG in the intron region) and sgRNA 2 (targeting 
sequences GGGTCTAAGACGTTGGTTT in the end of 3’UTR) were picked and went 
for fly embryo injection. The left homology arm around ~2kb and right arm around ~ 2kb 
were assembled together with dsRed cassette as described (Zhang et al., 2014b). The 
y[1], M(Act5C-Cas9 )ZH-2A, w[1118], Lig4[169] embryos were injected with donor 
plasmid at 800 ng/µl and sgRNAs at 272 ng/µl each. F1 flies with dsRed eyes were 
chosen for characterization by PCR and sequencing to confirm the insertion position of 
the selection cassette. Fly stocks with correct insertion were establish as fall[2]. For the 
RMCE exchange, a full length of fall-CDS, fall-∆BTB, and fall-∆ZFs were tagged with 
2xHA and cloned as described (Zhang et al., 2014b). The plasmids were injected to 
fall[2] fly embryos and the progeny were screened for non fluorescent red eyes and 
characterised by PCR and sequencing as described (Zhang et al., 2014b). 
Sarcomere length quantification 
Flies samples were staged to desired stage and dissected. The IFM were stained with 
rhodamine phalloidin and the 40X4 images were acquired with Leica 780. Then the 
sarcomere length was quantified by a macro that has been integrated into Fiji (written by 
Giovanni Cardone, unpublished) automatically. Sarcomere length from at least three 
images (independent flies) was measured for each group of sample. The two-tailed 
unpaired student t-test were performed between wt and fall[1] or fall[2]. Error bar 
represents standard deviation. 
mRNA-seq and proteomics analysis 
For mRNA-Seq, IFMs were dissected at either 30h APF or 48h APF and isolated based 
on Mef2-GAL4, UAS-GFP-Gma expression (Spletter et al., 2015). For the RNA-seq, 
three replicates were used and each replicate contains indirect flight muscles dissected 
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from 150 pupae. For the proteomics, the indirect flight muscles were labeled similarly 
with RNA-seq experiment. Three replicates were used and each replicate consists of 
indirect flight muscles dissected from 50 pupae.  
mRNA-Seq libraries were prepared as described previously (Spletter et al., 2015). 
Libraries were sequenced on an Illumina HiSeq 2500 and multiplexed 3-4 samples per 
lane, obtaining ~100 million reads per library. Sequencing was performed at the Vienna 
Biocenter Core Facility (VBCF) (http://www.vbcf.ac.at/facilities/next-generation-
sequencing/). Reads were filtered and trimmed using the FASTX Toolkit and cutadapt 
and mapped to the Flybase 2015_04 genome assembly using STAR {Dobin:2015by}. 
Reads were visualized on the USCS server by normalizing to the largest library size. 
Libraries were evaluated with featureCounts v1.4.2 {Liao:2014cj}, and differential 
expression analysis was performed with DESeq2 {Love:2014ka} or DEXSeq (Anders et 
al., 2012). Additional data processing was handled in R, using packages including 
ggplot2, GOplot, plyr, reshape2, VennDiagram and Mfuzz . GO analysis was performed 
with Gorilla (http://cbl-gorilla.cs.technion.ac.il/), REVIGO and GOElite (Supek	 et	 al.,	2011;	Zambon	et	al.,	2012). Gene set enrichment analysis was performed with GSEA 
{Subramanian:2005jt, Mootha:2003wx} using user-specified gene sets. Genes induced 
during IFM myofibril maturation are from a manuscript in preparation (Spletter, Zhang 
& Schnorrer). 
The samples for the proteomics were homogenized in 50 µl 6M of guanidinium chloride. 
Heat the samples at 95 degree for 3-5 min and then centrifuge at 14000g for 10 min. The 
supernatant was load on LC-MS according to a published protocol (Cox et al., 2014; 
Eberl et al., 2013). The data were preprocessed by MaxQuant (Cox and Mann, 2008) and 
then analyzed with Perseus(Tyanova et al., 2016). 
Dissection and Immunostaining 
All IFM dissections, if not specified, were performed with a modified procedure based 
on published protocol (Weitkunat and Schnorrer, 2014). Briefly, after removing of the 
pupal case from the staged samples, two to three holes were pinned in the abdomen with 
insect pins. The samples were then transferred to 4% PFA in PBST (0.5% Triton-X in 
PBS) and fixed for  ~ 20 min at room temperature (RT) on a belly dancer. Samples were 
transferred to a silicon coated petri dish and their position was fixed as described 
(Weitkunat and Schnorrer, 2014). Cut a hole on the head then continue the cutting to the 
abdomen along the ventral middle line. Other tissues in between of the two thorax halves 
were removed by forceps or blew away by pipetting. The two thorax halves were then cut 
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off and transferred to 24 well plate. The samples were washed with 3x PBST for 10 min 
each at RT before blocking with 5% NGS in PBST for 1 hour at RT. Afterwards, they 
were incubated with primary antibodies at 4 degree overnight and washed 3x in PBST 
(10 min each) at RT. Incubation with secondary antibodies were performed at RT for 2 
hours. The samples were washed again 3x in PBST and embedded in VECTASHIELD 
plus DAPI (H-1200, VECTEOR LABORATORIES) to visualise nuclei. The samples 
were stored at 4 degree before imaging. Images were acquired on a Zeiss LSM780 
confocal and processed with FIJI (ImageJ). 
To stain Su(Hw) and Mod(mdg4)67.2, the samples were dissected first in PBS or PBS + 
250mM NaCl (takes about 25-30 min) before fix with methanol. The fixation were done 
in precooled 100% methanol at -20 ºC for 15 min. Gently shake the 24 well plate every 5 
min during fixation. Afterwards, equal volume of PBST were added into the fixation 
solution slowly and mixed well. Then discard and wash the samples as described above 
before proceed to immunostaining. 
To induce osmotic stress, the samples were incubated in PBS + 250 mM NaCl or PBS + 
500 mM sucrose at RT for 30 min on a belly dancer before fixation. 
Antibodies and dilutions: 
For immunostaining, Rabbit anti-GFP (dilution 1:2000) was obtained from Amsbio 
(catalog number: TP401). Rat monoclonal anti-HA (3F10) and mouse monoclonal anti-
HA (16B12) were used at 1:500. Rabbit anti-CP190 (dilution 1:2000), mouse anti-CP190 
(dilution 1:1000), rabbit anti-Mod(mdg4)67.2 (dilution 1:1000) and rabbit anti-Su(Hw) 
(1:1000) were gifts from Professor Mariano Labrador (Schoborg et al., 2013). Mouse 
anti-BEAF-32 (dilution 1:20) {Blanton:2003gy}, mouse anti-β-PS (CF.6G11, dilution 
1:100) (Brower et al., 1984), mouse anti-futsch (22C10, dilution 1:100) 
{Zipursky:1984un}, mouse anti-laminDm0 (ADL67.10, dilution 1:50) (Riemer et al., 
1995), and mouse anti-HP1a (C19A, 1:100) {James:1986vk} were obtained from DSHB. 
Guinea pig anti-Shot (1:600) (Strumpf and Volk, 1998)was a gift from Talila Volk. All 
the primary antibodies were diluted in PBST with 5% NGS. All the secondary 
antibodies, including goat anti-mouse, goat anti-rat, goat anti-pig, and goat anti-rabbit, 
and phalloidin rhodamine were purchased from Molecular Probes and applied at 1:500 
dilution. 
For western blot, muscle fibers dissected from 10 pupae with desired stage were 
homogenized in 50 µl SDS buffer (250 mM Tris pH 6.8, 30% glycerol, 1% SDS, 500 
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mM DTT) then boiled at 95 degree for 5 min. The samples were centrifuged at 12000 
rpm for 5 min and 15 µl were loaded to each lane of a 4-12% gradient SDS-PAGE gel. 
Wet-transfer was performed at 300 mA for 30 min. PVDF membrane (Immobilon, 
Millipore) were blocked with 10% milk powder and then probed with primary antibodies 
respective antibodies. Rabbit anti-Gelsolin (dilution, 1:2000) {Stella:1994vz} was a gift 
from Maria Leptin. Rabbit anti-Flightin (dilution, 1:10000) (Reedy et al., 2000)was a gift 
from Jim Vigoreaux. Same laminD0 (ADL67.10, 1:2000) and HA (16B12, 1:2000) that 
mentioned above were used for WB. Goat anti-rabbit IgG (111-035-144, 1:20000) and 
goat anti-mouse (115-034-146, 1:10000) were obtained from Jackson ImmunoResearch. 
Visualization was performed with chemiluminescence (Millipore) and using a LAS4000 
detector system (FujiFilm). 
Flight test 
Flight tests were done as previously described (Schnorrer et al., 2010). Around 20-30 
fresh adult males (1-3 days after eclosion) were collected and recovered for 48 hours in 
the incubator at 27 degree. Flip the samples into the flight test cylinder that is divided 
into 5 zones. Record the landing position of the flies immediately after flipping and count 
the numbers of flies in each zone of the cylinder. 
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Results: 
Mutation of fallen angel (fall) results in muscle atrophy 
We had identified CG32121 in a genome-wide muscle-specific RNAi screen resulting in 
flightless animals with missing flight muscles in adults (Schnorrer et al., 2010). 
CG32121 is located on the third chromosome and encodes a BTB-zinc finger, for which 
no classical mutants were available (Figure 1A). We used our established TALEN and 
CRISPR protocols (Zhang et al., 2014a; 2014b) to  generate two new CG32131 deletion 
alleles. Both alleles result in viable but entirely flightless animals, hence gave CG32121 
the name fallen angel or fall for short (Figure 1B). The TALEN induced fall[1] allele 
contains a 363 bp deletion spanning the splice acceptor of the second exon and a large 
part of the BTB domain. In the CRISPR-induced fall[2] allele we exchanged most of the 
fall locus with a STOP cassette and a 3xP3-dsRed marker leaving only 38 amino acids of 
the original Fall protein (Figure 1A). Hence, we generated two fall alleles, with at least 
fall[2] likely being a null allele, confirming that fall is essential for flight. 
Histological analysis of the flight muscle morphology in fall homozygous or trans-
heterozygous mutants over a large fall deficiency showed that fall is required for flight 
muscle formation or maintenance in young adults (Figure 1E-J). Importantly, this muscle 
atrophy phenotype could be rescued by re-expressing Fall-GFP under its endogenous 
control using a GFP-tagged genomic fosmid construct (Sarov et al., 2016) (Figure 1K-
M), demonstrating that the fall loss of function phenotype is specific and that the fall-
GFP fosmid is functional. The fall phenotype can also be rescued by re-expressing fall-
HA only in the developing IFMs by flight muscle specific Act88F-GAL4 and UAS-fall-
HA (Figure 1N-P). Together, these data demonstrate that fall is required specifically in 
flight muscles to prevent flight muscle atrophy. 
Fall is required for sarcomere growth during development 
 In order to identify the cause for the muscle loss in fall mutants, we looked at IFM 
development during pupal stages. We found that flight muscle fibers look normal at 48 h 
APF in fall mutants and also the mutant sarcomeres have a wild-type morphology 
reaching a length of about 2.0 µm at 48 h APF (Figure 2A, E, I, M, R, W, Ab). This 
shows that myofibrillogenesis initiates normally and early sarcomeres are assembled. 
Also flight muscle innervation appears normal, ruling out that the atrophy is caused by 
missing innervation (Supplementary Figure 2). However, from 56 h APF onwards a 
progressive detachment of the IFMs in fall[1] was observed in most cases from the 
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posterior attachment sites (Figure 2B-D, F-H) and a severe muscle thinning resulting in 
muscle rupturing in fall[2] mutant IFMs (Figure 2I-L). Interestingly, this is accompanied 
by a severe sarcomere phenotype. At 48 h APF, most of the about 300 immature 
sarcomeres in each myofibril have been built in wild-type and fall mutant IFMs and are 
2.0 µm long. Whereas in wild type the sarcomeres grow synchronously after 48 h APF to 
reach a length of about 3.0 µm by 72 h APF, sarcomere length growth is entirely blocked 
in fall mutants remaining at about 2.0 µm in length (Figure 2M-Ab). This is accompanied 
by actin accumulations found in fall[2] myofibrils from 56 h onwards (Figure 2X-Z). 
This demonstrates a severe sarcomere maturation defect in fall mutants. As the pupal 
thorax and the attached muscle fibers also grow in length during this sarcomere 
maturation phase, the fall[1] muscles detach from the attachments sites and the fall[2] 
mutants fibers rupture within the fiber, as they cannot support the required growth. Re-
expression of fall with the late flight muscle specific driver fln-GAL4, which is only 
expressed after 48 h cannot rescue this fiber rupture phenotype (Supplementary Figure 
1). Together, these data suggest that Fall is required in the flight muscles to support 
sarcomere maturation and to prevent muscle fiber rupturing from 48 h APF onwards. 
fall mutant muscles produce uncontrolled high forces 
The muscle tearing and detachment phenotypes suggest an abnormally high force being 
present in the developing fall mutant flight muscles. In order to test if the phenotype is 
indeed dependent on force produced by the developing sarcomere, we crossed the fall 
mutants into a Mhc[10] background, which lacks most of the force producing Mhc in the 
flight muscles (Cripps et al., 1999). As expected, the muscle atrophy phenotype is 
entirely rescued in Mhc[10];fall double mutant flies (Figure 3A-F), suggesting that fiber 
tearing and detachment are indeed caused by uncontrolled high forces.  
Muscle attachments need to be able to withstand high forces and integrins are central 
players for muscle-tendon attachments (Brown, 2000). In order to rule out that 
attachment sites are abnormally weak in fall[1] mutants, we stained for integrin complex 
components, however did not find any difference to wild type at 48 h APF, thus not 
explaining the detachment at 56 h (data not shown). We further tried to artificially 
strengthen the attachment sites by over-expression of a dominant active form of Rap1 or 
providing an additional genomic copy of the IPP complex member Pinch, both of which 
were shown to strengthen muscle attachment sites in flies (Ellis et al., 2013; Pronovost et 
al., 2013; Vakaloglou et al., 2016). However, both strategies did not rescue the muscle 
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detachment phenotype of fall[1] mutants (Supplementary Figure 2D-H), suggesting that 
a weakness of the attachment sites is not the cause for the detachment phenotype. 
In order to investigate the detachment phenotype closer, we labeled the tendon cell 
membrane by expressing CD8-GFP with the tendon specific stripe-GAL4. At 56 h APF, 
the wild-type tendon cells show straight extensions from their basal side to the ends of 
the muscle fibers, where the integrin containing attachment sites are located (Figure 
3G,I,J). Surprisingly, tendon cell membrane labeled by the CD8-GFP remains at the 
detached end of the fall[1] mutant muscle fibers at 56 h APF, showing that the tendon 
extensions rupture into pieces and the connection to the tendon cell body is lost. This is 
the case for both anteriorly occurring detachments, which are more rare, and posteriorly 
occurring detachments, which are frequently observed (Figure 3H,K-N). Thus, the 
muscle-tendon junction remains intact and integrin remains at the end of the muscle 
fibers (Figure 3K''-L''). The remaining tendon cell debris attached the fall mutant muscle 
fiber ends are degraded until 72 h APF (Supplementary Figure 3). As this phenotype can 
be rescued by muscle specific expression of fall (see Figure 1) these data strongly 
suggest that the forces produced in fall[1] flight muscles are too high to be counteracted 
by normal tendon cells, resulting in tendon cell rupturing and eventually muscle atrophy. 
Fall is expressed in body muscle nuclei 
Having seen this dramatic developmental defect in fall mutant flight muscles we 
wondered where does Fall protein localize. To address this, we first analyzed Fall 
expression using the functional Fall-GFP fosmid construct. We found that Fall-GFP is 
expressed in the nuclei of all adult body muscles, including both indirect flight muscle 
types, the dorso-longitudinal (DLM) and the dorso-ventral muscles (DVM), as well as 
jump and leg muscles. Fall-GFP is however not expressed in visceral muscles or any 
other cell types (Figure 4A-E). To address the temporal dynamics of Fall expression, we 
investigated Fall localisation during flight muscle development. We found that Fall-GFP 
is not yet expressed during the initiation of myofibrillogenesis at 30 h APF (Figure 4F). 
Fall-GFP expression can be detected at low levels at 34 h in the flight muscle nuclei, its 
expression strongly increases until 48 h and remains high until 72 h APF (Figure 4G-J). 
These localization studies demonstrate the Fall-GFP is indeed a body muscle specific 
nuclear protein, whose expression is strongly induced during the myofibril and 
sarcomere maturation phase, nicely correlating with the observed phenotypic defect in 
sarcomere maturation in fall mutants. 
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Fall requires its BTB and Zn-finger domains to function 
After we had established the nuclear localization of Fall during muscle development we 
wanted to investigate the role of the different domains of Fall for sarcomere maturation. 
To address this important point, we used the CRISPR generated fall[2] allele that in 
addition to the STOP cassette and the 3x-P3dsRed marker also contains two flanking attP 
sites, which can be used for phiC31 recombinase mediated cassette exchange (Venken et 
al., 2011). We used this strategy to either insert a fall cDNA, tagged at the C-terminus 
with HA and fused in frame with the remaining 38 amino acids of the endogenous first 
fall exon, or a fall cDNA that is lacking the BTB or both zinc finger domains (Figure 
5A). All three HA tagged proteins are expressed at a comparable level and the flies are 
homozygous viable. However, only the fall-CDS-HA flies can fly, whereas fall-ΔBTB-
HA and fall-Δ-ZFs-HA are entirely flightless (data not shown). We analyzed the flight 
muscle morphology of these three different fall alleles and found that fall-CDS-HA has 
an entirely normal IFM morphology at 48 h and 72 h AFP and also its sarcomeres grow 
normally to a length of about 2.8 µm at 72 h APF (Figure 5B,E,H,K,N). In contrast, both 
fall-ΔBTB-HA and fall-Δ-ZFs-HA alleles display the typical myofiber rupture phenotype 
at 72 h APF likely caused by severe sarcomere growth defects with the sarcomere length 
remaining close to 2 µm at 72 h APF (Figure 5B-N). This demonstrates that Fall protein 
needs both, its BTB and its zinc finger domains, to support sarcomere maturation and 
flight muscle fiber integrity during muscle development. 
The BTB domain of BTB zinc finger proteins often mediates protein-protein interactions, 
whereas its zinc fingers are often implicated in binding to DNA (Siggs and Beutler, 
2012). We investigated the distribution of the full length and the deletion proteins during 
flight muscle development and interestingly found that in contrast to Fall-HA, Fall-
ΔBTB-HA is defective in nuclear enrichment. It apparently can enter the nuclei, but is 
not retained there, resulting in an equal distribution between cytoplasm and nuclei 
(Figure 5O,P). On the other hand Fall-Δ-ZFs-HA is normally localized in the muscle 
nuclei (Figure 5Q) but non functional, consistent with the interpretation that its zinc 
fingers are not required for nuclear localization but rather for its function, possibly for its 
interaction with DNA. 
Fall is a transcriptional regulator at sarcomere maturation stages 
 We found a sarcomere maturation defect in fall mutants. In order to directly test if Fall is 
indeed a transcriptional regulator during the stages of sarcomere maturation we dissected 
indirect flight muscles from wild type and fall[1] mutants at 30 h and 48 h APF and 
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performed mRNA-Seq analysis. In accordance with the wild type morphology and the 
absence of Fall expression at 30 h APF, we find very few transcriptional changes at 30 h 
APF (Figure 6A, Supplementary Table 1). In contrast, the expression of a large number 
of genes are changed at 48 h APF, including a large number of sarcomeric components 
being down-regulated in fall[1] (Figure 6B, Supplementary Table1). This demonstrates 
that Fall is indeed a transcriptional regulator during sarcomere maturation stages. 
We performed a bioinformatic analysis using GO categories and additional informative 
gene function lists. We found a significant down-regulation of transcription factors and 
sarcomeric components, as well as genes identified as the 'salm-core' set of genes 
dependent on Spalt function in flight muscle (Spletter et al., 2015). Additionally, we 
found a significant change in the mitochondrial metabolism, with glycolysis components 
being up-regulated, as well as pyruvate and fat metabolism being down-regulated. One of 
the most striking differences is found by the analysis of the 'gene cluster 22 set', which 
was defined as a set of genes being strongly induced during sarcomere maturation stages 
containing a strong enrichment of sarcomeric as well as mitochondrial components 
(Figure 6C) (Spletter, Zhang & Schnorrer, in prep.). The fly GO-term memberships are 
somewhat ill-defined, with many bona-fide sarcomeric proteins not listed with a 
sarcomeric GO-term, but rather with cytoskeleton related GO-terms. We find many of 
them including ZASP66, starvin, sarcomere length sort (sals), the titin homolog sallimus 
(sls) and bent (bt), the M-line components obscurin (unc-89) and mask, as well as 
paxillin (pax) being down-regulated in fall[1] muscles at 48 h APF (Figure 6D).  
It is challenging to verify all these mRNA expression changes at a protein level, as total 
proteome detection with mass-spectrometry from muscles has still limitations to quantify 
all proteins. Nevertheless, we have been able to confirm the down-regulation of a 
significant number of proteins, including the sarcomeric components Strn-Mlck and 
TpnC4 at 72 h APF, whereas other sarcomeric components, including TpnC73F and 
TpnC41C are aberrantly up-regulated  (Figure 6E, Supplementary Table 2). We used a 
genomic GFP fusion in ZASP66 to confirm its down-regulation at sarcomeric Z-discs of 
72 h APF flight muscles (Figure 6F). We had antibodies working for western blot 
detection available for Flightin (Fln) and Gelsolin (Gel) and could confirm its down- and 
up-regulations, respectively (Figure 6G). Taken together, these data strongly suggest that 
Fall is essential to regulate the induction of a large number of sarcomeric components 
during the stages of sarcomere growth in order to enable proper sarcomere maturation. 
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Fall localises to nuclear speckles 
By inspecting the Fall-GFP or Fall-HA nuclear localizations in greater detail, we realized 
that Fall localizes non homogenously throughout the muscle nuclei. These patterns 
reminded us of stress induced nuclear granules, which have been reported to regulated 
chromatin landscapes (Gómez-Díaz and Corces, 2014). In order to test if the Fall 
localization pattern in the nuclei is dynamic we treated semi-dissected hemi-thoraces of 
48 h APF for 30 min with PBS or PBS plus 250 mM NaCl and compared them to 
directly fixed samples. Interestingly, we find that the small Fall-GFP speckles that are 
found when directly fixed or treated just with PBS dynamically fuse to large speckles 
which preferentially cluster at the nuclear periphery after incubation in high salt (Figure 
7A-E).  
Generally, the recruitment of wild-type Fall protein into large speckles upon high salt 
treatment is not dependent on the developmental stage of the muscle and can be induced 
at 48 h, 72 h or 1 day adults with similar efficiencies (Figure 7C,L-O). It is also not only 
caused by high salt treatment but also by 30 min incubation with 500 mM sucrose 
(Supplementary Figure 4A), suggesting that large Fall speckles are induced by different 
kinds of osmotic stress. The recruitment of Fall into speckles is not a general 
phenomenon of all nuclear proteins as for example the localization of the 
heterochromatin protein HP1 does not change upon osmotic stress (Supplementary 
Figure 4B,C). These findings are in accordance with Fall being a dynamic transcriptional 
regulator, whose activity may be adjusted according to the status of the cell. 
In order to identify the domains in Fall required for the recruitment into large nuclear 
speckles, we treated 72 h APF thoraces of fall-CDS-HA and the fall deletions alleles with 
high salt. We found that Fall-CDS-HA and Fall-Δ-ZFs-HA are recruited into large 
speckles at 72 h APF, but the small amount of Fall-ΔBTB-HA that is present in the 
nucleus at 72 h APF is not localized to any speckled pattern (Figure 7F-H). This again 
demonstrates the importance of the Fall BTB domain for the normal localization of Fall, 
whereas the zinc finger domains are functionally required but do not show a difference in 
the localization pattern. 
Fall localization is distinct from insulator bodies defining a new nuclear body 
A similar dynamic re-localization upon osmotic stress as we found for Fall was described 
for a class of proteins that are generally coined insulator bodies, including CP190, 
BEAF-32, Su(Hw) and Mod(mdg4)67.2 (Schoborg et al., 2013). Interestingly, CP190 
and Mod(mdg4)67.2 also contain BTB domains. As these components are not expressed 
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in a tissue specific manner but rather ubiquitous, we hypothesized that Fall may be a 
muscle specific component of the insulator complex. We used the Fall-GFP or Fall-HA 
flies to investigate the recruitment of Fall into insulator bodies defined by BEAF32, 
CP190, Su(Hw) and Mod(mdg4)67.2. Surprisingly, we found that although all five 
components are recruited to large speckles upon osmotic stress, the Fall speckles or 
droplets are in close proximity to neither overlap with the CP190 or BEAF32 pattern 
(Figure 8A-D) nor with the Su(Hw) or Mod(mdg4)67.2 speckles (Supplementary Figure 
5A-D). We also observed that the overlap between the bona-fide insulator complex 
members CP190 and BEAF-32 is not complete upon insulator or droplet formation, 
whereas CP190 and Mod(mdg4)67.2 overlap very well in flight muscle after osmotic 
stress (Figure 8E,F). These data may suggest that there are a larger number of nuclear 
speckles or insulator bodies existing. Furthermore, they may share important features 
with the recently described nuclear lipid droplets, which supposedly are used to segregate 
different nuclear proteins (Mitrea and Kriwacki, 2016; Zhu and Brangwynne, 2015). It is 
important to note that most of the generally accepted important insulator complex 
components appear to be dispensable for normal development. Null or strong 
hypomorphic alleles for CTCF, a additional core insulator member (Mohan et al., 2007), 
BEAF-32 or CP190 are viable or only pharate lethal and their flight muscles do not 
display any obvious gross defects (Supplementary Figure 5E-H). Together, these data 
suggest that Fall, in contrast to the classical insulator complex components, has an 
essential role for sarcomere maturation during flight muscle development and may fulfill 
this role by using a novel type of nuclear speckle or droplet domain to function. 
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Discussion 
In this study we have investigated the mechanism controlling the transcriptional 
induction of sarcomeric components to enable normal sarcomere maturation and growth 
during flight muscle development of Drosophila. We have identified the BTB-zinc finger 
protein Fallen Angel as essential transcriptional regulator, which is crucial for the 
boosted expression of a subset of sarcomeric components after immature myofibrils and 
sarcomeres have been built. This ensures that sarcomeres can mature to its normal 
pseudo-crystalline pattern found in the adult. 
In a recent systematic developmental mRNA sequencing study we found a biphasic 
expression for many sarcomeric components, with a lower induction before the initiation 
of myofibrillogenesis resulting in the formation of immature sarcomeres. This is 
followed by a substantial transcriptional boost during sarcomere maturation, coinciding 
with sarcomeric growth from 1.7 µm to 3.2 µm in the adult (Spletter, Zhang & 
Schnorrer, in prep). This work defined a cluster containing a subset of sarcomeric 
components and a number of mitochondrial components to be strongly induced during 
sarcomere maturation. Interestingly, this cluster of genes strongly depends on Fall 
protein function, with many sarcomeric and mitochondrial components not being induced 
in fall mutants. This defined Fall as a novel transcriptional regulator with particular 
phenotype, distinct from all other known transcriptional regulators in muscle, a specific 
regulator of sarcomere maturation. 
Fall requires both its BTB domain and the zinc finger domains to fulfill its function. As 
the BTB domain is required for the correct nuclear localization of Fall and is a likely 
interaction platform with other proteins (Siggs and Beutler, 2012), it is fair to assume 
that Fall does not act alone but within a larger molecular complex to regulate its targets. 
To date, we can only speculate about the nature of this complex. We have shown that 
Fall dynamically localizes to a novel class of nuclear bodies, which are in proximity but 
distinct from the well described insulator bodies, that similarly to Fall respond to osmotic 
stress (Schoborg et al., 2013).  
Our findings are consistent with a recent model of liquid phase separation controlling 
transcriptional decisions in general and the formation of so called super-enhancers in 
particular (Hnisz et al., 2017). At super-enhancers, a large amount of transcriptional 
activators are concentrated in a cooperative manner, potentially using principles of liquid 
phase separation. These enhancers are particularly active resulting in very high 
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expression rates (Lovén et al., 2013). As sarcomeric proteins require very high induction 
rates in order to enable normal sarcomere maturation a similar liquid phase complex 
containing Fall and other factors may boost the expression of these components during 
sarcomere maturation. 
We have shown here that the correct stoichiometry of the sarcomeric components is 
critical for normal muscle force production during development. In the likely 
hypomorphic fall[1] allele sarcomere growth is entirely blocked, but sarcomeric 
architecture is initially relatively preserved, no actin accumulations are visible. These 
fall[1] mutant fibers can produce such high forces from 56 h APF onwards that the 
attached tendon cells rupture into pieces, showing that in wild type muscle force 
production must be tightly regulated. The muscle fibers of the fall null allele fall[2] 
rupture within the muscles, likely because the compromised sarcomeric and myofibril 
architecture with the actin accumulations cannot withstand the high forces, thus the 
muscle and not the tendon cells rupture. The result in both alleles is the same: the muscle 
fibers are disconnected from the tendons cells and undergo severe muscle atrophy. This 
demonstrates the importance of controlled sarcomere maturation and force production for 
muscle function and muscle cell survival. 
To date, it is unclear if vertebrates have a functional ortholog of Fall. BTB-zinc fingers 
are a large and divers family, in which only the BTB and the zinc-finger domains are 
preserved (Siggs and Beutler, 2012). With regular BLAST searches a Fall ortholog in 
vertebrates cannot be defined. However, a recent study identified mutations in human 
ZBTB42 as a cause for a lethal congenital contracture syndrome, caused by uncontrolled 
muscle hyper-contraction (Patel et al., 2014). Knock-down of the zebrafish ZBTB42 also 
resulted in a severe muscle phenotype (Patel et al., 2014). Thus, we speculate that 
ZBTB42 might be a functional ortholog of Fall in human skeletal muscle, ensuring the 
proper stoichiometry of the sarcomeric components to control force production during 
skeletal muscle development. 
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Figures 
 
Figure 1: Fall is required for IFM development or fall is required in muscle to prevent 
muscle atrophy 
A: Gene and protein structure of fall;  
B: TALEN mediated deletion scheme of fall[1];  
C: CRISPR based deletion scheme of fall[2];  
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D: Flight test;  
E-J: Dissected adult hemithoraces of wild type (E), fall[1] (F), fall[2] (G), wild type over 
fall deficiency (H), fall[1] over fall deficiency (I), fall[2] over fall deficiency (J);  
K-M: Rescue of fall mutation with a GFP tagged Fosmid line Fall-GFP: fall-GFP (K), 
fall[1], fall-GFP (L), fall[2], fall-GFP (M);  
N-P: Tissue specific rescue of fall alleles with IFM specific driver: Actin88f-GAL4; 
fall[1] (N), Actin88f-GAL4; fall[1],UAS-fall-HA/fall[1] (O), Actin88f-GAL4; 
fall[2],UAS-fall-HA/fall[2] (P).  
For flight test, around 20-30 flies were flipped into the 1 meter long cylinder and the 
landing position was recorded. The respective percentages of each zone were calculated 
as the number of flies in that zone over total tested flies. Scale bar represents 100 µm. 
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Figure 2: fall is required for sarcomere maturation during muscle growth 
A-D’’: Rhodamine-phalloidin staining of developing IFM from 48h APF to 90h APF in 
wild type (A-D), fall[1] (A’- D’), fall[2] (A’’- D’’); The red arrows point to contracted 
muscle fiber tips; green arrows point to ruptured muscle fibers.  
E-I’’: Developing myofibrils and sarcomeres from 48h APF to 90h APF in wt (E-I), 
fall[1] (E’- I’), fall[2] (E’’- I’’); Actin blobs are frequently seen at 56h APF in fall[2] 
(white arrowhead). H’ and H’’ were taken from green-boxed region in C’ and C’’, 
respectively. I’ and I’’ were taken from red-boxed region in C’ and C’’. Scale bar 
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represents 100 µm in A-D’’ and 5 µm in E-I’’. Images in A-D’’ and E-I’’ are cropped to 
the same size, respectively.  
J: Sarcomere length quantification, *P<0.05, ***P < 0.001, two tailed unpaired Student’s 
t-test. Error bar represents the ± s.d. from at least three samples for each group.  
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Figure 3: fall loss of function causes muscle hypercontraction during sarcomere 
maturation 
A-F: Dissected young adult hemithoraces of wild type (A), fall[1] (B) and fall[2] (C) 
Mhc[10] (D), Mhc[10]; fall[1] (E), and Mhc[10]; fall[2] (F). Note that intact IFM fibers 
are retained in E-F. 
G-N’’’: Tendon cell and extensions are labelled with UAS-CD8-GFP; stripe-GAL4. 
Dissected 56h APF pupal hemithoraces were stained for GFP, β-PS, and shot of UAS-
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CD8-GFP; stripe-GAL4, fall[1]/+ (G), UAS-CD8-GFP; stripe-GAL4, fall[1]/+ (H). 
High magnification of muscle tendon junction (white boxed region) at anterior end (I-
I’’’) and posterior end (J-J’’’) of UAS-CD8-GFP; stripe-GAL4, fall[1]/+; High 
magnification of anterior tendon cells (K-K’’’) and ruptured muscle tips (L-L’’’), as well 
as  posterior ruptured muscle tips (L-L’’’) and tendon cells (K-K’’’) of UAS-CD8-GFP; 
stripe-GAL4, fall[1]/fall[1]. Note that β-PS specifically localizes to muscle fiber tips and 
tendon cell extension debris was seen at both anterior and posterior ruptured muscle tips. 
Scale bars are 100 µm in A-F and 10 µm in I-J’’’and K-N’’’. Images of A-C, D-F, I-J’’’, 
and K-N’’’ are cropped to the same size, respectively.  
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Figure 4: Fall is localised in body muscle nuclei 
A-E’’: Dissected fall-GFP adult body muscles are stained for GFP and DAPI. GFP are 
seen in DLM (A-A’’), DVM (B-B’’), jump muscle (C-C’’), and leg muscle (D-D’’) but 
absent in visceral gut muscle (E-E’’). 
F-J’’: Dissected fall-GFP developing IFMs are stained for GFP and DAPI at 30h APF 
(F-F’’), 34h APF (G-G’’), 48h APF (H-H’’), 60h APF (I-I’’), and 72h APF (J-J’’). Fall-
GFP starts to express at 34h APF and reach high level at 48h APF in IFM nuclei. Note 
that Fall-GFP displays a discrete small dot pattern. 
Scale bars are 5 µm in all cases. Images of A-E’’ and F-J’’ are cropped to the same size, 
respectively. 
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Figure 5: Both BTB and ZFs are required for Fall function 
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A: fall-CDS-HA (B), fall-ΔBTB-HA (C), and fall-ΔZFs-HA (D) are insert to fall 
endogenous locus by phiC31 integrase mediated RMCE. 
B-G: Dissected 48h APF and 72h APF pupal hemithoraces of fall-CDS-HA (B, E), fall-
ΔBTB-HA (C, F), and fall-ΔZFs-HA (D, G), Muscle fibers ruptured in F and G. 
H-J: Myofibrils and sarcomeres of fall-CDS-HA (H), fall-ΔBTB-HA (I), and fall-ΔZFs-
HA (J) at 72h APF.  
K-M: Relative intensity profile of a representative myofibrils from image H (K), image I 
(L), and image J (M). Sarcomeres are shorter in I/L and J/M. 
N: Quantification of sarcomere length of fall-CDS-HA, fall-ΔBTB-HA, and fall-ΔZFs-HA 
at 72h APF. ***P < 0.001, two-tailed unpaired Student’s t-test. Error bar represents the ± 
s.d. from at least three samples for each group. 
O-Q’: Localization pattern of Fall-CDS-HA (O-O’), Fall-ΔBTB-HA (P-P’), and Fall-
ΔZFs-HA (Q-Q’) at 48h APF. Note that Fall-ΔBTB-HA localizes to cytoplasm rather 
than nuclei. Scale bars represent 100 µm in B-D and 5 µm in H-J and O-Q’. Images of B-
D, E-G, H-J, and O-Q’ are cropped to the same size, respectively. 
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Figure 6: Fall regulates a large group of genes that are required for sarcomere maturation 
or Fall modulates transcription during sarcomere maturation stage. 
A-B: Volcano plot of significantly changed genes (DESeq2, p<0.05, log2FC>1) of fall[1] 
vs wild type RNA-seq at 30h APF (A) and 48h APF (B). Blue dots indicate significant 
changed genes, green dots indicate insignificant changed genes, and red dots indicate 
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overlay with sarcomere genes. Note, at 30h, only few genes are significantly changed and 
no sarcomere genes changed. At 48h, many genes changed and sarcomere genes tend to 
be low expressed in fall[1]. 
C: Volcano plot of fall[2] vs wild type proteomics at 72h APF. Red dots indicate overlay 
with sarcomere genes. 
D: GSEA analysis of user-specified gene sets including sarcomere genes, salmcore 
genes, cluster 22 (a genes set that are induced at sarcomere maturation stage, Maria 
unpublished) and mitochondria related genes. Note that the sarcomere genes, salmcore 
genes and cluster 22 genes are significant enriched to a down regulation trend in fall[1]. 
The trend of down regulation is indicated by Normalised Enrichment Score. 
E: Significantly down regulated genes at 48h APF in fall[1] are analysed by GOElite. 
Representative significantly enriched GO terms and genes are picked and visualised by 
Chordplot.  
F: Dissected 72h APF IFM from ZASP66-GFP (a-a’’), Fall[1],Zasp-66 (b-b’’), fall[2], 
Zasp66-GFP (c-c’’). In fall[1] and fall[2], Zasp66-GFP level is significantly lower and 
no obvious periodic localization is seen. 
G: Western blot of 56h APF wild type, fall[1], fall[2] IFM protein samples, probed for 
Lamin (control), Flightin and Gelsolin. Flightin level in fall[1] and fall[2] are 
significantly lower than wild type, while it is opposite for Gesolin. 
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Figure 7: Fall forms nuclear body like structure or Fall localizes to liquid droplets in 
muscle nuclei upon osmotic stress 
A-C’’: Fall-GFP localization pattern at 48h APF without (A-B’’) or with 30 min NaCl 
treatment (C-C’’). Dissected IFM samples are stained for GFP, DAPI, and lamin.  
D-E: Orthogonal view of single representative nucleus from untreated (D) and treated 
sample (E). Fall-GFP nuclear body localized to the nuclear membrane periphery that 
labeled by lamin. 
F-H’: Localization pattern of Fall-CDS-HA (F-F’’’), fall-ΔBTB-HA (G-G’’’), and fall-
ΔZFs-HA (H-H’’’) at 72h APF without (F-H and F’-H’) or with 30 min of 250 mM NaCl 
treatment (F’’-H’’ and F’’’-H’’’). Fall-ΔBTB-HA failed to enter nuclear bodies after 
osmotic treatment. 
I-J’’’: Fall-CDS-HA localization pattern at 72h APF (I-I’’’) and 1 day old adult (J-J’’’). 
Samples are stained for HA and DAPI. 
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Scale bars represent 5 µm in all images. Images of A-C’’ and F-J’’’ are cropped to the 
same size, respectively 
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Figure 8: Fall-GFP nuclear body does not overlap with insulator bodies 
A-B’’: Dissected 48h APF IFMs from fall-GPF are stained for GFP (A and B) and 
CP190 (A’), and BEAF-32 (B’). 
C-D’’: Dissected 48h APF IFMs from fall-GPF are treated with 250 mM NaCl for 30min 
and then stained for GFP (C and D) and CP190 (C’), and BEAF-32 (D’). In the merged 
image, Fall-GFP does not colocalize with CP190 or BEAF-32, but appears that 
associated with CP190 (C’’). 
E-F’’: Dissected 48h APF IFMs from wild type are treated with 250 mM NaCl for 30min 
and then stained for BEAF-32 (E), CP190 (E’ and F’), and Mod(mdg4)67.2 (F). CP190 
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and BEAF-32 (E’’) are associated but not complete overlap while CP190 and 
Mod(mdg4)67.2 (F’’) are completely overlapped. 
Scale bars represent 5 µm in all images and all images are cropped to the same size 
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Supplementary Figures 
 
Supplementary Figure 1: Fln-GAL4; UAS-fall-HA failed to rescue fall mutants. 
A-A’’ and B-B’’: Dissected adult hemithoraces were stained for F-actin (A, B) and HA 
(A’, B’) of fln-GAL4/+; fall[2], UAS-fall-HA/+ (A-A’’) and fln-GAL4/+; fall[2], UAS-
fall-HA/fall[2] (B-B’’). 
A’’’ and B’’’: Myofibril and sarcomere morphology of fln-GAL4/+; fall[2], UAS-fall-
HA/+ and fln-GAL4/+; fall[2], UAS-fall-HA/fall[2]. 
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White arrows point to the ruptured muscle fibers and white arrowhead points to irregular 
sarcomeres. Scale bar is 100 µm in A-A’’ and B-B’’ as well as 5 µm in A’’’-B’’’.  
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Supplementary Figure 2: IFM neuronal pattern in fall[1] and fall[2] is similar to wild 
type; MTJ reinforcement by overexpressing constitutively active form Rap1 or Pinch did 
not rescue muscle rapture in fall[1] 
A-C: IFM neuronal patterns at 48h APF are revealed by Futsch staining in wild type (A), 
fall[1] (B), and fall[2] (C).  
D-F’’: Overexpression of GFP-Rap1 constitutively active form in IFM. 76h APF hemi-
thoraces are stained for GFP and F-actin in control Actin88f-GAL4/+;fall[1]/+ (D-D’’), 
Actin88f-GAL4/+; fall[1] (E-E’’), and Actin88f-GAL4/+;UAS-GFP-Rap1-CA/+; fall[1] 
(F-F’’).  
G-H: 76h APF of Pinch-FL; fall[1]/+ (G) and Pinch-FL; fall[1] (H).  
Scale bar are 100 µm in all cases. Images of (A-C), (D-F’’), and (G-H) are cropped to the 
same size, respectively.  
Appendices 
 
 104 
 
Supplement Figure 3: Tendon cell debris degraded at 72h APF. 
A-D: Dissected 72h APF hemi-thoraces stained for exact the same proteins in Figure 3 
(G-N’’’). Tendon debris is absent at muscle tips. 
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Supplement Figure 4: Fall-GFP response to sucrose treatment; Fall-GFP nuclear body 
does not co-localize with HP1 
A-A’’: Fall-GFP localization pattern after sucrose treatment. 
B-C’’: Fall-GFP nuclear body does not colocalize with HP1. 
Scale bars represent 5 µm in all images. All images are cropped to the same size. 
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Supplementary Figure 5: Fall-HA does not co-localize with Su(Hw) or Mod(mdg4)67.2; 
Insulator proteins mutants do not display obvious IFM phenotype. 
A-B’’: Dissected 48h APF IFMs from fall-CDS-HA are stained for HA (A and B) and 
Su(Hw) (A’), and Mod(mdg4)67.2 (B’). 
C-D’’: Dissected 48h APF IFMs from fall-CDS-HA are treated with 250 mM NaCl for 
30min and then stained for HA (C and D) and Su(Hw) (C’), and Mod(mdg4)67.2 (D’). In 
the merged image (C’’and D’’), Fall-HA does not colocalize with Su(Hw) or 
Mod(mdg4)67.2. 
E-H: Dissected pharate or 1 day adult hemithoraces of CTCF[GE24185] (E), 
CTCF[GE24185]CTCF/[P30.6] (F), BEAF-32[AB-KO] (G), and CP190[1]/CP190[2] 
(H). All of them showed intact IFM fibers in the thorax. 
Scale bars represent 5 µm in A-D’’ and 100 µm in E-H. . Images of A-D’’ and E-H are 
cropped to the same size, respectively 
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